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CHAPTER-I 
 INTRODUCTION  
 
ORAL DRUG DELIVERY SYSTEM 
The oral route of drug administration is the most important method of administration of 
drug for systemic effect, despite of tremendous advancement in drug delivery system. Its ease of 
administration, pain avoidance and various advantages over other routes is the reason that the 
oral route achieved such popularity. But the most evident drawback of oral dosage forms like 
tablets and capsules is difficulty in swallowing, leading to patient’s incompliance particularly in          
and films) may show greater patient acceptability and convenience.  
Fast-dissolving oral delivery systems are solid dosage forms, which disintegrate or 
dissolve within 1 min when placed in the mouth without drinking of water. After disintegrating 
in mouth, enhanced the clinical effect of drug through pre-gastric absorption from mouth 
pharynx and oesophagus as the saliva passes down into the stomach. In such cases, 
bioavailability of drug is significantly greater than those observed from conventional tablet 
dosage form. More recently, Fast-dissolving drug delivery systems have rapidly gained 
acceptance as an important new way of administering drugs. They are usually used for 
pharmaceutical and nutraceutical products. It is the newest frontier in drug delivery technology 
that provides a very convenient means of taking medications and supplements. Fast dissolving 
drug delivery system are also applicable when local action in the mouth is desirable such as local 
anesthetic for toothaches, oral ulcers, cold sores, or teething.  
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This novel drug delivery system can also be beneficial for meeting the current needs of 
the industry are improved solubility/stability, biological half-life and bioavailability 
enhancement of drugs. (Kaur et al., 2012) 
 
Overview of Oral Mucosa 
The oral cavity comprises the lips, cheek, tongue, hard palate, soft palate and floor of the 
mouth. The lining of the oral cavity is referred to as the oral mucosa, and includes the buccal, 
sublingual, gingival, palatal and labial mucosa. The buccal, sublingual and the mucosal tissues at 
the ventral surface of the tongue account for about 60% of the oral mucosal surface area. The top 
quarter to one-third of the oral mucosa is made up of closely compacted epithelial cells. The 
primary function of the oral epithelium is to protect the underlying tissue against potential 
harmful agents in the oral environment and from fluid loss. Beneath the epithelium are the 
basement membranes, lamina propia and submucosa. The oral mucosa also contains many 
sensory receptors including the taste receptors of the tongue. Three types of oral mucosa can be 
found in the oral cavity; the lining mucosa is found in the outer oral vestibule (the buccal 
mucosa) and the sublingual region (floor of the mouth). The specialized mucosa is found on the 
dorsal surface of tongue, while the masticatory mucosa is found on the hard palate (the upper 
surface of the mouth) and the gingival (gums). The lining mucosa comprises approximately 60%, 
the masticatory mucosa approximately 25%, and the specialized mucosa approximately 15% of 
the total surface area of the oral mucosal lining in an adult human. The masticatory mucosa is 
located in the regions particularly susceptible to the stress and strains resulting from masticatory 
activity. The superficial cells of the masticatory mucosa are keratinized, and a thick lamina 
propia tightly binds the mucosa to the underlying periosteum. Lining mucosa on the other hand is 
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not nearly as subject to masticatory loads and consequently, has a non-keratinized epithelium, 
which sits on a thin and elastic lamina propia and a sub mucosa. The mucosa of the dorsum of 
the tongue is a specialized gustatory mucosa, which has well papillated surfaces which are both 
keratinized and some non-keratinized. 
Schematic representation of the different linings of mucosa in mouth 
 
 
ORALLY DISINTEGRATING DOSAGE FORMS 
 The concept of orally disintegrating dosage forms has emerged from the desire to provide 
patients with more conventional means of taking their medication. Interestingly, the demand for 
ODDFs has enormously increased during the last decade, particularly for geriatric and pediatric 
patients who experience difficulty in swallowing conventional tablets and capsules. Hence, they 
do not comply with prescription, which results in high in33cidence of ineffective therapy.   
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                           Schematic diagram of buccal mucosa          
 
 
 The advantages and disadvantages associated with utilizing the oral mucosa as a drug delivery 
site  
Advantages Disadvantages 
Accessible Permeability barrier of oral mucosa 
Self-administrable Saliva washes away the drug  
Oral mucosa repairs rapidly Mastication and speech may 
dislodged 
Different areas of the oral cavity have 
different permeability characteristics 
Delivery device 
Highly hydrated environment to 
dissolve drug 
Requires formulation for agreeable 
taste 
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Sustained delivery possible Highly enzymatic environment 
Potential reduction of systemic side 
effects 
Relatively small surface area 
Avoid the hepatic first pass effect Risk of choking on or swallowing 
delivery device 
 
 In disease conditions such as motion sickness, sudden episodes of attacks of coughing 
and repeated emesis swallowing conventional solid dosage forms become difficult. Orally 
disintegrating dosage forms can serve as an effective alternative mode of drug delivery in such 
situations. When put in the mouth, these dosage forms disintegrate instantly to release the drug, 
which dissolves or disperses in the saliva. Thereafter, the drug may get absorbed from the 
pharynx and esophagus or from other sections of GIT as the saliva travels down. In such cases, 
bioavailability is significantly greater than that observed from conventional tablet dosage form. 
 The novel technology of oral disintegrating dosage forms is known as fast dissolve, rapid 
dissolve, rapid melt and quick dispersible tablets (Gupta et al, 2010). However, the function and 
concept of all these dosage forms are similar. 
 Different orally disintegrating dosage forms are as follows: 
1. Orally disintegrating tablets: 
 It is a tablet that dissolves or disintegrates in the oral cavity without the need of water or 
chewing. 
2. Fast dissolving films:  
The fear of taking solid tablets and the risk of choking for certain patient population still 
exists despite their short dissolution and disintegration time. It consists of very thin oral strip, 
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which releases the active ingredient immediately after uptake in to the oral cavity. It combines all 
advantages of tablets along with liquid dosage forms. This system is simply placed on patients 
tongue or any other mucosal surface, instantly wet by saliva; film rapidly hydrates and dissolves 
to release the medication.  
3. Fast Caps:  
A new type of fast disintegrating drug delivery system based on gelatin capsules was 
developed. In contrast to conventional hard gelatin capsules, the fast caps consist of gelation of 
low bloom strength and various additives to improve the mechanical and dissolution properties 
of capsule shell. It includes several advantages like high drug loading, possible solid and liquid 
filling, and no compression of coated taste masked or extended release drug particles / pellets, 
good mechanical properties, simple manufacturing, mechanical stability and requirement of 
special packaging.  
4. Medicated chewing gums: 
 It is an attractive alternative for drug delivery system with several advantages including 
convenience for administration, mainly chewing gum is used to promising controlled release 
drug delivery system. These are mainly available currently for pain relief, smoking cessation, 
travel illness and freshening of breath. 
5. Freeze-dried wafer:  
It is a quick-disintegrating, thin matrix that contains a medicinal agent that does not need 
water for swallowing. This fragile dosage form requires unit-dose packaging to ensure physical 
stability. The wafer disintegrates instantaneously in the oral cavity and releases drug, which 
dissolves or disperses in the saliva. The saliva is swallowed and the drug is absorbed across the 
gastrointestinal tract (GIT). (Priyanka Nagar et al., 2011) 
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CHAPTER-II 
FAST DISSOLVING TABLET - A REVIEW 
Drug delivery systems (DDS) are a strategic tool for expanding 
markets/indications, extending product life cycles and generating opportunities. Oral 
administration is the most popular route for systemic effects due to its ease of ingestion, 
pain, avoidance, versatility and most importantly, patient compliance. Also solid oral 
delivery systems do not require sterile conditions and are therefore, less expensive to 
manufacture. Patient compliance, high-precision dosing, and manufacturing efficiency 
make tablets the solid dosage form of choice. Excipients and equipments choices will be 
significantly affected should solid dosage form technologies change in response to the 
unprecedented shifts in the drug discovery such as genomics. Should next generation drugs 
are predominantly protein or peptide based, tablets may no longer be the dominant format 
give the difficulty of dosing such moiety. Injections generally are not favored for use by 
patients unless facilitated by sophisticated auto injectors. Inhalation is one good alternative 
system to deliver these drugs, but the increased research into biopharmaceuticals so far has 
generate predominantly chemical entities with low molecular weights. The development of 
enhanced oral protein delivery technology by Fast dissolving Tablets which may release 
these drugs in the mouth are very promising for the delivery of high molecular weight 
protein and peptide . The oral route remains the perfect route for the administration of 
therapeutic agents because the low cost of therapy, manufacturing and ease of 
administration lead to high levels of patient compliance. (Rajeshree Panigrahi et al., 2010) 
The problem of swallowing is common phenomenon in geriatric patient due to fear 
of choking, hand tremors, dysphasia and in young individuals due to underdeveloped 
muscular and nervous systems and in schizophrenic patients which leads to poor patient 
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compliance. Difficulties in swallowing of tablet and capsule are also occurring when water 
is not available, in diarrhea, coughing during the common cold, allergic condition and 
bronchial infection. Approximately one-third of the population (mainly pediatric and 
geriatric) has swallowing difficulties, resulting in poor compliance with oral tablet drug 
therapy which leads to reduced overall therapy effectiveness. For these reason, tablets that 
can rapidly dissolve or disintegrate in the oral cavity have attracted a great deal of attention 
(Md.Nehal Siddiqui et al., 2010). 
United States Food and drug administration (FDA) defined fast dissolving tablet 
(FDT) as “a solid dosage form containing medicinal substance or active ingredient which 
disintegrate rapidly usually within a matter of seconds when placed upon the tongue.” 
European pharmacopoeia has used the term “Orodispersible tablet” for tablets that 
disperses readily and within 3 min in mouth before swallowing.( Johnny Edward Aguilar-
Diaz et al., 2012) 
 
DESIRED CHARACTERISTICS OF FAST DISSOLVING TABLETS 
Because administration of FDTs is different from administration of conventional 
tablets, the FDTs should maintain several unique properties, as listed below (V.Dinesh 
kumar et al., 2011). 
Fast Disintegration 
FDTs should disintegrate in the mouth without additional water or with a very 
small amount (e.g., 1–2 ml) of water. The disintegration fluid is provided by the saliva of 
the patient. The disintegrated tablet should become a soft paste or liquid suspension, which 
can provide good mouth feel and smooth swallowing. The “fast disintegration” usually 
means disintegration of tablets in less than 1 minute, but it is preferred to have 
disintegration as soon as possible. 
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Taste of Active Ingredients 
Because FDTs dissolve or disintegrate in the patient’s mouth, the drug will be 
partially dissolved in close proximity to the taste buds. After swallowing, there should be 
minimal or no residue in the mouth. A pleasant taste inside the mouth becomes critical for 
patient acceptance. An ideal taste-masking technology should provide drugs without 
grittiness and with good mouth feel. The amount of taste masking materials used in the 
dosage forms should be kept low to avoid excessive increase in tablet size. The taste-
masking technology should also be compatible with FDT formulations.  
Drug Properties 
For the ideal FDT technology, the drug properties should not significantly affect 
the tablet property. Many drug properties could potentially affect the performance of 
FDTs. For example, the solubility, crystal morphology, particle size, hygroscopicity, 
compressibility, and bulk density of a drug can significantly affect the final tablets 
characteristics, such as tablet strength and disintegration. The FDT technology should be 
versatile enough to accommodate unique properties of each drug. 
Tablet Strength and Porosity 
Because FDTs are designed to have a quick dissolution/disintegration time, the 
tablet porosity is usually maximized to ensure fast water absorption into the tablets. The 
key properties of the tablets are fast absorption or wetting of water into the tablets and 
disintegration of associated particles into individual components for fast dissolution. This 
requires that excipients should have high wettability, and the tablet structure should also 
have a highly porous network. Because the strength of a tablet is related to compression 
pressure, and porosity is inversely related to compression pressure, it is important to find 
the porosity that allows fast water absorption while maintaining high mechanical strength. 
In addition, low compression pressure causes fast dissolving dosage forms to be soft, 
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friable, and unsuitable for packaging in conventional blisters or bottles. A strategy to 
increase tablet mechanical strength without sacrificing tablet porosity or requiring a special 
packaging to handle fragile tablets should be provided. 
Moisture Sensitivity 
FDTs should have low sensitivity to humidity. This problem can be especially 
challenging because many highly water soluble excipients are used in formulation to 
enhance fast dissolving properties as well as to create good mouth feel. Those highly 
water-soluble excipients are susceptible to moisture; some will even deliquesce at high 
humidity. A good package design or other strategy should be created to protect FDTs from 
various environmental conditions. 
Ion Exchange Resin 
 One of the popular approaches in the taste masking of bitter drugs is based on IER. 
IER are solid and suitably insoluble high molecular weight polyelectrolytes that can 
exchange their mobile ions of equal charge with the surrounding medium.Being high 
molecular weight water insoluble polymers, the resins are not absorbed by the body and 
are therefore inert. The long-term safety of IER, even while ingesting large doses as in the 
use of cholestyramine to reduce cholesterol is an established unique advantage of IER due 
to the fixed positively or negatively charged functional groups attached to water insoluble 
polymer backbone. These groups have an affinity for oppositely charged counter ions, thus 
absorbing the ions into the polymer matrix. Since most drugs possess ionic sites in their 
molecule, the resin's charge provides a means to loosely bind such drugs and this complex 
prevents the drug release in the saliva, thus resulting in taste masking. For taste masking 
purpose weak cation exchange or weak anion exchange resins are used, depending on the 
nature of drug. The nature of the drug resin complex formed is such that the average pH of 
6.7 and cation concentration of about 40meq/L in the saliva are not able to break the drug 
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resin complex but it is weak enough to break down by hydrochloric acid present in the 
stomach. Thus the drug resin complex is absolutely tasteless with no after taste, and at the 
same time, its bioavailability is not affected. 
Classification of IER 
 IERs contain positively or negatively charged sites and are accordingly classified 
as either cation or anion exchanger. The functional group in cation exchanger and anion 
exchanger undergoes reaction with the cations and anions of the surrounding solution 
respectively. The strong cation exchanger contains sulphuric acid sites whereas weak 
cation exchangers are based on carboxylic acid moieties. The strong anion exchange resins 
have quaternary amine ionic sites attached to the matrix, whereas weak anion exchanger 
has predominantly tertiary amine substituents. Detail of IERs is available which are 
summarized in Table. 
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Properties of IER 
a) Particle size 
 Decreasing the size o
for the reaction to reach equ
size affords a slower release 
b) Porosity  
       The limiting size of the i
on the porosity. The porosity
                     FAST DISSOLVING TABLE
IER – DRUG COMPLEX
f the resin particles significantly decreases 
ilibrium with the surrounding medium; hen
pattern. 
ons, which can penetrate into a resin matrix, 
 depends upon the amount of cross-linking 
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ce larger particle 
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Polymerization method. The amount of swelling is directly proportional to the number of 
hydrophilic functional groups attached to the polymer matrix and is inversely proportional 
to the degree of DVB cross linking present in the resin. 
c) Cross-linking 
 The percentage of cross-linking affects the physical structure of the resin particles. 
Resins with low degree of cross-linking can take up large quantity of water and swell into 
a structure that is soft and gelatinous. However resins with high (Divinylbenzene) DVB 
content swell very little and are hard and brittle. 
d) Exchange capacity 
 The exchange capacity refers to the number of ionic sites per unit weight or volume 
(mEq. Per gram or meq per ml). The weight basis values (mEq. per gm) is much higher 
than the volume based exchange capacity since the wet resin is highly hydrated. The 
exchange may limit the amount of drug that may be adsorbed on a resin, hence affect 
potency of the complex. Carboxylic acid resins derived from acrylic acid polymers have 
higher exchange capacities (10meq. /gm) than sulfonic acid (about 4meq. / gm) or amine 
resins because of bulkier ionic substituents and the polystyrene matrix. Therefore, higher 
drug percentages may often be achieved with carboxylic acid resins. 
e) Acid base strength 
 It depends on various ionogenic groups incorporated into resins. Resins containing 
sulphonic, phosphonic or carboxylic acid exchange groups have approximate pKa values 
of <1, 2, 3 and 4-6 respectively. Anionic exchangers are quaternary, tertiary or secondary 
ammonium groups having pKa values of >13, 7-9 or 5-9 respectively. The pKa values of 
resin will have significant influence on the rate at which the drug will be released in the 
gastric fluid. 
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f) Selectivity of resin for counter ion 
 Since IER involves electrostatic forces, selectivity mainly depends on relative 
charge and ionic radius of hydrated ions competing for an exchange site and to some 
extent on hydrophobicity of competitor ion. 
Salient Features of Fast Dissolving Drug Delivery System  
• Ease of administration to patients who refuse to swallow a tablet, such as paediatric 
and geriatric patients and, psychiatric patients. 
• Convenience of administration and accurate dosing as compared to liquids. 
• No need of water to swallow the dosage from, which is highly convenient feature 
for patients who are traveling and do not have immediate access to water. 
• Good mouth feels properly of MDDS helps to change the basic view of medication 
as "bitter pill", particularly for pediatric patients. 
• Rapid dissolution of drug and absorption which may produce rapid, onset of action. 
• Some drugs are absorbed from the month pharynx and oesophagus as the saliva 
passes down into the stomach, in such cases bioavailability of drugs is increased. 
• Ability to provide advantages of liquid medication in the form of solid preparation. 
      (Bhupendra G Prajapadti et al., 2009).  
Requirements of Fast Dissolving Tablets  
An ideal FDT should 
 Have a pleasing mouth feel. 
  Require no water for oral administration, yet dissolve / disperse/ disintegrate in     
mouth in a matter of seconds. 
  Have an acceptable taste masking property. 
  Be harder and less friable 
  Exhibit low sensitivity to environmental conditions (temperature and humidity).  
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  Allow the manufacture of tablet using conventional processing and packaging 
            Equipments. (Bhupendra G Prajapadti et al., 2009). 
Advantages of ODTs  
1. ODT can be administer to the patients who cannot swallow tablets/cap., such as the 
elderly, stroke victims, bedridden patients, patients with esophageal problems & 
patients who refuse to swallow such as pediatric, geriatric & psychiatric  patients 
and thus improves patient compliance . 
2. It contain the certain studies which concluded increased bioavailability and proved 
rapid absorption of drugs through pregastric absorption of drugs from mouth, 
pharynx & esophagus as saliva passes down . 
3. ODT is most convenient for disabled, bedridden patients, travelers and busy 
people, who do not always have access to water.  
4. Good mouth feel property of ODT helps to change the perception of medication. 
5. As bitter pill particularly in pediatric patients.  
6. The risk of chocking or suffocation during oral administration of conventional 
formulations due to physical obstruction is avoided, thus providing improved 
safety. 
7. ODT opened new business opportunity like product differentiation, product 
promotion, patent extension and life cycle management. 
8. Suitable during traveling where water may not be available. 
9. No specific packaging required can be packaged in push through blisters. 
10. Conventional manufacturing equipment. 
11. Cost effective. 
12. Good chemical stability as conventional oral solid dosage form. 
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13. New business opportunity like product differentiation, product promotion, patent       
extension and life style management. 
14. Allow high drug loading. 
15. Provides rapid drug delivery from dosage forms. 
16. Provide advantage of liquid medication in form of solid Preparation. 
17. Rapid drug therapy intervention. 
18. No chewing needed. 
19. Adaptable and amenable to existing processing and packaging Machinery. 
20. Rapid onset of action. 
Disadvantages of ODTs  
1. ODT is hygroscopic in nature so must be keep in dry place. 
2. Some time it possesses mouth feeling. 
3. It is also shows the fragile, effervescence granules property. 
4. ODT requires special packaging for properly stabilization & safety of stable 
product. (Priyanka Nagar et al., 2011) 
SELECTION OF FDT DRUG CANDIDATES:  
Several factors must be considered when selecting drug candidates for delivery as FDT 
dosage forms. 
 The drugs which have significantly different pharmacokinetic profiles compared 
with the same dose administered in a conventional dosage. E.g. selegiline, 
apomorphine, buspirone etc. 
 The drugs that produce a significant amount of toxic metabolites mediated by first 
pass liver metabolism and gastric metabolism and for drugs that have a substantial 
fraction of absorption in the oral cavity and segments of the pre-gastric GIT.  
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  Drugs having ability to diffuse and partition into the epithelium of the upper GIT 
(log P > 1, or preferable > 2); and those able to permeate oral mucosal tissue are 
considered ideal for FDT formulations.  
  Patients who concurrently take anticholinergic medications may not be the best 
candidates for these drugs.  
  Patients with Sjögren’s syndrome or dryness of the mouth due to decreased saliva 
production may not be good candidates for FDT formulations. 
  Drugs with a short half-life and frequent dosing.  
  Drugs which are very bitter or otherwise unacceptable taste because taste masking 
cannot be achieved.  
  Drugs which require controlled or sustained release are unsuitable candidates of 
fast dissolving oral dosage forms. 
  Pharmaceutical Companies have formulated FDT for various categories of drugs 
such as neuroleptics, cardiovascular agents, analgesics, antiallergic, antiepileptics, 
anxiolytics, sedatives, hypnotics, diuretics, anti-parkinsonism agents, anti-bacterial 
agents and drugs used for erectile dysfunction (Md.Nehal Siddiqui et al., 2010). 
MECHANISMS OF ODTs  
ODTs involve the following mechanisms to achieve the desired fast dissolving 
characteristics  
1. Water must quickly enter into the tablet matrix to cause rapid disintegration and 
instantaneous dissolution of the tablet. 
2. Incorporation of an appropriate disintegrating agent or highly water soluble excipients in 
the tablet formulation. 
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3. There are some under mentioned mechanisms by which the tablet is broken down into 
the smaller particles and then subsequently result a solution or suspension of the drug. 
(Susijit Sahoo et al., 2010) 
 The mechanisms are- 
• High swellability of disintegration 
• Chemical reaction 
• Capillary action.  
Challenges in Formulating ODTS 
Palatability 
As most drugs are unpalatable, orally disintegrating drug delivery systems usually 
contain the medicament in a taste-masked form. Delivery systems disintegrate or dissolve 
in patient’s oral cavity, thus releasing the active ingredients which come in contact with 
the taste buds; hence, taste-masking of the drugs becomes critical to patient compliance.  
Mechanical strength 
In order to allow ODTs to disintegrate in the oral cavity, they are made of either 
very porous and soft-molded matrices or  compressed into tablets with very low 
compression force, which makes the tablets friable and/or brittle, difficult to handle, and 
often requiring specialized peel-off blister packing that may add to the cost. 
Hygroscopicity 
Several orally disintegrating dosage forms are hygroscopic and cannot maintain 
physical integrity under normal conditions of temperature and humidity. Hence, they need 
protection from humidity which calls for specialized product packaging. 
Amount of drug 
The application of technologies used for ODTs is limited by the amount of drug 
that can be incorporated into each unit dose. For lyophilized dosage forms, the drug dose 
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must be lower than 400 mg for insoluble drugs and less than 60 mg for soluble drugs. This 
parameter is particularly challenging when formulating a fast-dissolving oral films or 
wafers. 
Aqueous solubility 
Water-soluble drugs pose various formulation challenges because they form 
eutectic mixtures, which result in freezing-point depression and the formation of a glassy 
solid that may collapse upon drying because of loss of supporting structure during the 
sublimation process. Such collapse sometimes can be revented by using various matrix-
forming excipients such as mannitol than can induce crystallinity and hence, impart 
rigidity to the amorphous composite. 
Size of tablet 
The degree of ease when taking a tablet depends on its size. It has been reported 
that the easiest size of tablet to swallow is 7-8 mm while the easiest size to handle was one 
larger than 8 mm. Therefore, the tablet size that is both easy to take and easy to handle is 
difficult to achieve.  
Rapid disintegration 
  MDT is required to disintegrate rapidly in matter of seconds. 
 
Taste and mouth feel characteristics 
Approved sweeteners and flavours are typically included to achieve a palatable 
formulation, but additional taste masking strategies may also be required such as ion 
exchange resin and active pharmaceutical ingredient encapsulation. 
Avoid increase in size 
The tablet size of the MDT need to be monitored and is kept small to maintain the 
characteristic of rapid disintegration. 
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Good package design 
Packing requirements need to be considered early in the development process to 
protect MDTs from moisture and other environmental hazards (Jaysuhk J Hirani et al., 
2009). 
EXCIPIENTS COMMONLY USED FOR FDT PREPARATION 
It contains an active principle, mixture of excipients comprising atleast one 
disintegrant, a diluents and optionally a swelling agent, a permeabilizing agent, sweeteners 
and flavourings. 
The ingredients used are of food grade and helps to impart desired organoleptic 
properties and product efficacy (Deshmukh Keshav Ram et al., 2011). 
Superdisintegrants 
The basic approach in FDTs is use of disintegrant. Disintegrant play an important 
role in the disintegration and dissolution of FDT. It is essential to choose a suitable 
disintegrant, in an optimum concentration, so as to ensure quick disintegration and high 
dissolution rates. 
Superdisintegrant provide quick disintegration due to combined effect of swelling and 
water absorption by the formulation. Due to swelling of superdintegrant, the wetted 
surface of the carrier increases; thus promotes the wettability and dispersibility of the 
system, thus enhancing the disintegration and dissolution. (Siraj Shaikh et al., 2010). 
The optimization of tablet disintegration as commonly done by mean of the 
disintegration critical concentration .Below this concentration the tablet disintegration time 
is inversely proportional to the disintegrant concentration. Above the critical 
concentration, the disintegration time remains approximately constant or even increased 
(Amol V.Patil et al., 2011). 
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Example of some superdintegrants: 
• Croscarmellose sodium (Vivasol, Ac-Di-Sol) 
• Crospovidone (Polyplasdone) 
• Carmellose(NS-300) 
• Sodium starch glycolate(SSG) 
• Indion-414 
• Low substituted Hydroxy propyl cellulose. 
Binders  
Proper selection of a binder or combination of binder is essential to maintain 
integrity and stability of the tablet and to achieve desired sensory and melting 
characteristics. Binding agent may be liquid, semi-solid and slid or mixtures of varying 
molecules weights. (Desmukh Keshav Ram et al., 2011) 
E.g. cellulosic polymers, povidones, polyvinyl alcohols and acrylic polymers. 
Bulking agents  
  It improves the textural characteristics that in turn enhance disintegration in mouth. 
Recommended bulking agents for this delivery system should be more sugar – based such 
as mannitol, lactitol and starch hydrolysate for higher aqueous solubility and good sensory 
perception. Bulking agents are added in the range of 10 % to about 90% by weight of the 
final composition. (Desmukh Keshav Ram et al., 2011) 
Lubricants  
It assists in making tablets palatable and provides quicker disintegration. It 
removes grittiness and assists in drug transport mechanism from mouth down to stomach. 
Flavours and sweeteners 
Flavours and taste masking agents make the products more palatable and pleasing 
for patients. The addition of these ingredients assists in overcoming bitterness and 
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undesirable tablets of some active ingredients. Both neutral and synthetic flavors can be 
used to improve the organoleptic characteristics of FDTs. 
Eg: Dextrose, fructose, aspartame, sodium saccharin, sugar alcohols and sucralose. 
METHODOLOGY EMPLOYED FOR FAST DISSOLVING FORMULATIONS  
1. Melt granulation  
Melt granulation technique is a process by which pharmaceutical powders are 
efficiently agglomerated by a meltable binder. The advantage of this technique compared 
to a conventional granulation is that no water or organic solvents is needed. Because there 
is no drying step, the process is less time consuming and uses less energy than wet 
granulation. It is a useful technique to enhance the dissolution rate of poorly water-soluble 
drugs, such as griseofulvin. This approach to prepare FDT with sufficient mechanical 
integrity, involves the use of a hydrophilic waxy binder (Superpolystate, PEG - 6 - 
stearate).  
2. Phase transition process  
It is concluded that a combination of low and high melting point sugar alcohols, as 
well as a phase transition in the manufacturing process, are important for making FDTs 
without any special apparatus. FDT were produced by compressing powder containing 
erythritol (melting point: 122 °C) and xylitol (melting point: 93 95 °C), and then heating at 
about 93 °C for 15 min. After heating, the median pore size of the tablets was increased 
and tablet hardness was also increased. The increase of tablet hardness with heating and 
storage did not depend on the crystal state of the lower melting point sugar alcohol.  
3. Sublimation  
In this method a subliming material like camphor, is removed by sublimation from 
compressed tablets and high porosity is achieved due to the formation of many pores 
where camphor particles previously existed in the compressed tablets prior to sublimation 
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of the camphor. A high porosity was achieved due to the formation of many pores where 
camphor particles previously existed in the compressed Mannitol tablets prior to 
sublimation of the camphor. These compressed tablets which have high porosity 
(approximately 30%) rapidly dissolved within 15 seconds in saliva. Granules containing 
nimesulide, camphor, Crospovidone, and lactose were prepared by wet granulation 
technique. Camphor was sublimed from the dried granules by vacuum exposure. 
Conventional methods like dry granulation, wet granulation and direct compression with 
highly soluble excipients, superdisintegrants and/or effervescent systems can also be used.  
4. Three-dimensional Printing (3DP)  
Three-dimensional printing (3DP) is a rapid prototyping (RP) technology. 
Prototyping involves constructing specific layers that uses powder processing and liquid 
binding materials. A novel fast dissolving drug delivery device (DDD) with loose powders 
in it was fabricated using the three dimensional printing (3DP) process. Based on 
computer-aided design models, the DDD containing the drug acetaminophen were 
prepared automatically by 3DP system. It was found that rapidly disintegrating oral tablets 
with proper hardness can be prepared using TAG. The rapid disintegration of the TAG 
tablets seemed due to the rapid water penetration into the tablet resulting from the large 
pore size and large overall pore volume. 
5. Mass Extrusion 
This technology involves softening of the active blend using the solvent mixture of 
water soluble polyethylene glycol and methanol and expulsion of softened mass through 
the extruder or syringe to get a cylindrical shaped extrude which are finally cut into even 
segments using heated blade to form tablets. This process can also be used to coat granules 
of bitter drugs to mask their taste.  
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6. Spray Drying  
In this technique, gelatin can be used as a supporting agent and as a matrix, 
Mannitol as a bulking agent and sodium starch glycolate or Croscarmellose or 
Crospovidone are used as superdisintegrants. Tablets manufactured from the spray-dried 
powder have been reported to disintegrate in less than 20 seconds in aqueous medium. The 
formulation contained bulking agent like Mannitol and lactose, a superdisintegrant like 
sodium starch glycolate & Croscarmellose sodium and acidic ingredient (citric acid) and/or 
alkaline ingredients (e.g. sodium bicarbonate). This spray-dried powder, which 
compressed into tablets showed rapid disintegration and enhanced dissolution. Maximum 
drug release and minimum disintegration time were observed with Kollidon CL excipient 
base as compared to tablets prepared by direct compression, showing the superiority of the 
spray dried excipient base technique over direct compression technique. 
7. Cotton Candy Process 
The Shearform technology is employed in the preparation of a matrix known as 
‘floss’, made from a combination of excipients, either alone or with drugs. The floss is a 
fibrous material similar to cotton-candy fibers, commonly made of saccharides such as 
sucrose, dextrose, lactose and fructose at temperatures ranging between 180–266 °F. 
However, other polysaccharides such as polymaltodextrins and polydextrose can be 
transformed into fibers at 30–40% lower temperature than sucrose. This modification 
permits the safe incorporation of thermolabile drugs into the formulation. The tablets 
manufactured by this process are highly porous in nature and offer very pleasant mouth 
feel due to fast solubilization of sugars in presence of saliva. The manufacturing process 
can be divided into four steps as detailed below.  
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a) Floss Blend  
In this step, 80% sucrose in combination with mannitol/dextrose and 1% surfactant 
is blended to form the floss mix. The surfactant acts as a crystallization enhancer in 
maintaining the structural integrity of the floss fibers. It also helps in the conversion of 
amorphous sugar into crystalline form from an outer portion of amorphous sugar mass and 
subsequently converting the remaining portion of the mass to complete crystalline 
structure. This process helps to retain the dispersed drug in the matrix, thereby minimizing 
migration out of the mixture. 
b) Floss Processing  
The floss formation machine uses flash heat and flash flow processes to produce 
matrix from the carrier material. The machine is similar to that used in ‘cotton-candy’ 
formation which consists of a spinning head and heating elements. In the flash heat 
process, the heat induces an internal flow condition of the carrier material. This is followed 
by its exit through the spinning head (2000–3600 rpm) that flings the floss under 
centrifugal force and draws into long and thin floss fibers, which are usually amorphous in 
nature. 
c) Floss Chopping and Conditioning  
This step involves the conversion of fibers into smaller particles in a high shear 
mixer granulator. The conditioning is performed by partial crystallization through an 
ethanol treatment (1%) which is sprayed onto the floss and subsequently evaporated to 
impart improved flow and cohesive properties to the floss.  
d) Blending and Compression  
Finally, the chopped and conditioned floss fibers are blended with the drug along 
with other required excipients and compressed into tablets. In order to improve the 
mechanical strength of the tablets, a curing step is also carried out which involves the 
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exposure of the dosage forms to elevated temperature and humidity conditions, (40 °C and 
85% RH for 15 min). This is expected to cause crystallization of the floss material that 
results in binding and bridging to improve the structural strength of the dosage form. 
8. Tablet Molding  
Molding process is of two type’s i.e. solvent method and heat method. Solvent 
method involves moistening the powder blend with a hydro alcoholic solvent followed by 
compression at low pressures in molded plates to form a wetted mass (compression 
molding). The solvent is then removed by air-drying. The tablets manufactured in this 
manner are less compact than compressed tablets and possess a porous structure that hastens 
dissolution. The heat molding process involves preparation of a suspension that contains a 
drug, agar and sugar (e.g. mannitol or lactose) and pouring the suspension in the blister 
packaging wells, solidifying the agar at the room temperature to form a jelly and drying at 
30°c. 
9. Lyophilization or Freeze-Drying 
Freeze drying is the process in which water is sublimed from the product after it is 
frozen. This technique creates an amorphous porous structure that can dissolve rapidly. A 
typical procedure involved in the manufacturing of ODT using this technique is mentioned 
here. The active drug is dissolved or dispersed in an aqueous solution of a carrier/polymer. The 
mixture is done by weight and poured in the walls of the preformed blister packs. The trays 
holding the blister packs are passed through liquid nitrogen freezing tunnel to freeze the drug 
solution or dispersion. Then the frozen blister packs are placed in refrigerated cabinets to 
continue the freeze-drying. After freeze-drying the aluminum foil backing is applied on a 
blister-sealing machine. Finally the blisters are packaged and shipped. The freeze-drying 
technique has demonstrated improved absorption and increase in bioavailability. The major 
disadvantages of lyophillization technique are that it is expensive and time consuming; 
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fragility makes conventional packaging unsuitable for these products and poor stability under 
stressed conditions.  
10. Direct Compression  
Direct compression represents the simplest and most cost effective tablet 
manufacturing technique. This technique can now be applied to preparation of ODT because of 
the availability of improved excipients especially superdisintegrants and sugar based 
excipients. 
a) Superdisintegrants: 
      In many orally disintegrating tablet technologies based on direct compression, the 
addition of superdisintegrants principally affects the rate of disintegration and hence the 
dissolution. The presence of other formulation ingredients such as water-soluble excipients and 
effervescent agents further hastens the process of disintegration. For the success of fast 
dissolving tablet, the tablet having quick dissolving property which is achieved by using the 
super disintegrants,  
b) Sugar Based Excipients:  
This is another approach to manufacture ODT by direct compression. The use of sugar 
based excipients especially bulking agents like dextrose, fructose, isomalt, lactilol, maltilol, 
maltose, mannitol, sorbitol, starch hydrolysate, polydextrose and xylitol, which display high 
aqueous solubility and sweetness, and hence impart taste masking property and a pleasing 
mouthfeel. 
11. Nanonization 
Nanonization involves reduction in the particle size of drug to nanosize by milling the 
drug using a proprietary wet-milling technique. The nanocrystals of the drug are stabilized 
against agglomeration by surface adsorption on selected stabilizers, which are then 
incorporated into MDTs. This technique is especially advantageous for poor water soluble 
drugs. (A. Gupta et al., 2010). 
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PATENTED TECHNOLOGIES  
Zydus technology:  
This technology includes physical trapping of the drug in a matrix composed of a 
saccharide and a polymer. Polymers generally employed are partially hydrolyzed gelatin, 
hydrolyzed dextran, dextrin, alginates, polyvinyl alcohol, polyvinyl pyrrolidine, acacia, 
and these mixtures. The methodology involves solution or dispersion of components 
prepared and filled in to blister cavities, which are frozen in a liquid nitrogen environment. 
The frozen solvent is removed or sublimed to produce porous wafers. 
Lyoc:  
Lyoc technology is patented by PHARMALYOC. Oil in water emulsion is 
prepared and placed directly into blister cavities followed by freeze-drying. Non-
homogeneity during freeze-drying is avoided by incorporating inert filler to increase the 
viscosity finally the sedimentation. High proportion of filler reduces porosity of tablets due 
to which disintegration is lowered. 
Quick solv:  
This technology is patented by Janssen Pharmaceuticals. It utilizes two solvents in 
formulating a matrix, which disintegrates instantly. Methodology includes dissolving 
matrix components in water and the solution or dispersion is frozen. Then dry the matrix 
by removing water using an excess of alcohol (solvent extraction). Thus the product 
formed has uniform porosity and adequate strength for handling. 
Nanocrystal technology:  
This is patented by Elan, King of Prussia. Nanocrystal technology includes 
lyophilization of colloidal dispersions of drug substance and water-soluble ingredients 
filled in to blister pockets. This method avoids manufacturing process such as granulation, 
blending, and tabletting, which is more advantageous for highly potent and hazardous 
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drugs. As manufacturing losses are negligible, this process is useful for small quantities of 
drug. 
Flashtab technology: 
This is patented by Ethypharm France. This technology includes granulation of 
excipients by wet or dry granulation method and followed by compressing into tablets. 
Excipients used in this technology are of two types. Disintegrating agents include 
reticulated polyvinylpyrrolidine or carboxy methylcellulose. Swelling agents include 
carboxy methylcellulose, starch, modified starch, microcrystalline cellulose, carboxy 
methylated starch, etc. These tablets have satisfactory physical resistance. Disintegration 
time is within 1 min. 
Orasolv technology:  
This technology is patented by CIMA Labs. This includes use of effervescent 
disintegrating agents compressed with low pressure to produce the MDTs. The evolution 
of carbon dioxide from the tablet produces fizzing sensation, which is a positive 
organoleptic property. Concentration of effervescent mixture usually employed is 20-25% 
of tablet weight. As tablets are prepared at low compression force, they are soft and fragile 
in nature. This initiated to develop Paksolv, a special packaging to protect tablets from 
breaking during storage and transport. Paksolv is a dome-shaped blister package, which 
prevents vertical movement of tablet within the depression. Paksolv offers moisture, light, 
and child resistance packing. 
Durasolv technology:  
This technology is patented by CIMA Labs. The tablets produced by this 
technology utilize the conventional tableting equipment. Tablets in this are formulated by 
using drug, nondirect compression fillers, and lubricants. Nondirect compressible fillers 
are dextrose, mannitol, sorbitol, lactose, and sucrose, which have advantage of quick 
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dissolution and avoid gritty texture, which is generally present in direct compressible 
sugar. The tablets obtained are strong and can be packed in conventional packing in to 
bottles and blisters.  
Wow tab technology: 
Yamanouchi patented this technology. WOW means without water. This 
technology utilizes conventional granulation and tableting methods to produce MDTs 
employing low- and high-moldability saccharides. Low moldability saccharides are 
lactose, mannitol, glucose, sucrose, and xylitol. High-moldability saccharides are maltose, 
maltitol, sorbitol, and oligosaccharides. When these low- and high-moldable saccharides 
are used alone tablets obtained do not have desired properties of rapid disintegration and 
hardness, so combinations are used. This technology involves granulation of low-moldable 
saccharides with high-moldable saccharides as a binder and compressing into tablets 
followed by moisture treatment. Thus tablets obtained showed adequate hardness and rapid 
disintegration. 
Dispersible tablet technology:  
Lek, Yugoslavia patents this technology. It offers development of MDTs with 
improved dissolution rate by incorporating 8-10% of organic acids and disintegrating 
agents. Disintegrating agent facilitates rapid swelling and good wetting capabilities to the 
tablets that results in quick disintegration. Disintegrants include starch, modified starches, 
microcrystalline cellulose, alginic acid, cross-linked sodium carboxy methyl cellulose and 
cyclodextrins. Combination of disintegrants improves disintegration of tablets usually less 
than 1 min.  
 
 
 
CHAPTER-II                                        FAST DISSOLVING TABLET A REVIEW 
 
Madurai Medical College Page 31 
 
Pharmaburst technology:  
SPI Pharma, New Castle, patents this technology. It utilizes the co-processed 
excipients to develop MDTs, which dissolves within 30-40 s. This technology involves dry 
blending of drug, flavour, and lubricant followed by compression into tablets. Tablets 
obtained have sufficient strength so they can be packed in blister packs and bottles.  
Frosta technology: 
This technology patents by Akina. It utilizes the concept of formulating plastic 
granules and compressing at low pressure to produce strong tablets with high porosity. 
Plastic granules composed of:  
• Porous and plastic material,  
• Water penetration enhancer, and  
• Binder  
The process involves usually mixing the porous plastic material with water 
penetration enhancer and followed by granulating with binder. The tablets obtained have 
excellent hardness and rapid disintegration time ranging from 15 to 30 s depending on size 
of tablet. 
Oraquick:  
This technology is patented by K.V.S. Pharmaceuticals. It utilizes taste masking 
microsphere technology called as micromask, which provides superior mouth feel, 
significant mechanical strength, and quick disintegration/dissolution of product. This 
process involves preparation of microparticles in the form of matrix that protects drug, 
which can be compressed with sufficient mechanical strength. Low heat of production in 
this process makes it appropriate for heat sensitive drugs. Oraquick product dissolves 
within few seconds (M. Swamivelmanickam et al., 2010). 
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CHAPTER-III 
LITERATURE REVIEW 
Syusuke Sano et al., 2011. Prepared and evaluated of swelling induced –orally 
disintegrating tablets by microwave irradiation. In this study, to improve the 
opposing properties in a molded tablet using a one - step procedure that exploits the 
swelling induce by microwave treatment. Swelling of microwave irradiation 
observed high ratio of silicon dioxide and low levels of water volume. The results 
indicate that the disintegration time was clearly shortened by indication of the 
swelling. It was concluded that the one-step method using microwave irradiation 
would be useful method for preparing the ODTs. 
Sona P.S. et al., 2011. Formulated and evaluated taste masked orally disintegrating 
tablets of Diclofenac sodium. In this study, the bitter taste of Diclofenac sodium 
was masked by adding Veegum (Magnesium aluminium silicate). Granules of 
Diclofenac sodium were prepared using different ratio of veegum by wet 
granulation method. Diclofenac sodium orally disintegrating tablets were prepared 
by direct compression method using different concentration of two various 
superdisintegrants like Sodium starch glycolate, Croscarmellose sodium. The 
formulation containing Croscarmellose sodium has more wetting time than Sodium 
starch glycolate. It was concluded that the concentration of superdisintegrants 
increases disintegration time, dispersion time and In-vitro dissolution time 
decreases. Based on these tests the formulation containing 5% of sodium starch 
glycolate and croscarmellose sodium were selected as the optimum formulations. 
CHAPTER-III                                                                    LITERATURE REVIEW        
 
Madurai Medical College Page 33 
 
Devakar Rao Kalakuntla et al., 2011. Designed and developed taste masking 
Lornoxicam orodispersible tablet. The bitter taste of L Lornoxicam was masked by 
complexation with Eudragit E-100.The drug-Eutragit E-100 polymer complex was 
prepared by simple mass extrusion technique using syringe. Direct compression 
method was used to prepare ODT tablets. Two different disintegrants (Indion-414, 
SSG) in different ratio were used. The results concluded that the formulation 
containing Indion-414 (6%) was selected as the best formulation .It showed least 
disintegration time and the high percentage drug release. 
Ajaykumar Patil et al., 2011. Formulated and evaluated of mouth dissolving 
tablets of Montelukast sodium. In this study, the MDT was prepared by direct 
compression method. Two different superdisintegrants like Croscarmellose sodium, 
Crospovidone in different concentration were added. The disintegration of the 
tablets decreased with increase in the concentration of Crospovidone. The rapid 
drug dissolution was observed in the formulation containing Croscarmellose 
sodium, this may be attributed to rapid swelling and disintegration of a tablet and so 
the formulation containing Croscarmellose sodium was selected as the best 
formulation. 
Panwar. A.S. et al.., 2011. Formulated and evaluated fast dissolving tablet of 
Piroxicam. In this study, the FDT was prepared by direct compression method. 
Using solid dispersion of superdisintegrant like SSG, which improve the 
disintegration process. The tablet formulation was developed from Piroxicam-SSG 
(1:4) solid dispersion using microcrystalline cellulose as diluents. Other excipients 
like aerosol, sodium saccharin were added. It was concluded that the solid 
dispersion of Piroxicam-SSG markedly improved the dissolution of Piroxicam 
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powder. Since the formulation SSG included in solid dispersion from was found in 
much higher concentration than general concentration of solid dispersion in other 
tablet dosage form. 
Kirankumar.B et al., 2011, formulated developed and evaluated fast dissolving 
tablet of carvedilol using superdisintegrants and solid dispersion technique. In this 
study, the fast dissolving tablets were prepared using superdisintegrants like Ac-Di-
Sol, SSG and polymer is PEG by solid dispersion with dry granulation method.  The 
formulation containing Drug-PEG 4000 (1:4) by using combination of two 
superdisintegrants in 2 % concentration showed the best drug release. This ensures 
that solid dispersion technique have reduced the drug particle size and changes the 
microenvironment of the drug particles, which increases the rate of dissolution and 
absorption of poorly water soluble drugs. 
Sunil Makwana.H et al., 2010, Formulated and evaluated taste masked 
Orodispersible tablet of Ondansetron hydrochloride .The bitterness taste of 
Ondansetron hydrochloride was masked by making drug-resin complex with 
Indion-204.The drug-resin complex was prepared by batch method. Drug-resin 
complex were optimized by considering parameters such as resin concentration, 
swelling time, stirring time, pH, temperature on maximum drug loading. The 
Ondansetron hydrochloride Orodispersible tablet was prepared by direct 
compression method. Indion-414 was selected as   a superdisintegrant. The 
dissolution studies of tablets showed more than 90% of drug release within 15 
minutes. The complexation of Ondansetron HCL with Indion-204 increases 
acceptability and palatability of formulated rapid disintegrating tablets within 15 
minutes. 
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Dipti Gohil.Y. et al., 2010, Formulated and characterised Bambuterol 
hydrochloride fast dissolving tablet using various superdisintegrants. In this study, 
the FDT formulations were prepared by direct compression method by using 
different concentrations of various superdisintegrants such as SSG, CP, CCS and 
Pregelatinised starch. In dissolution studies, the maximum increase in the 
dissolution rate was observed with 12 % crospovidone amongst the 
superdisintegrants. The order of enhancement of the dissolution rate with various 
superdisintegrants was found to be Crospovidone > Croscarmellose sodium > 
Sodium starch glycolate > Pregelatinised starch. 
Venkada Ramana Reddy.S et al., 2010, Formulated, developed and compared 
different compressed oral disintegrating tablets. The ODT formulations were 
prepared by using different drug like Granisetron hydrochloride, Memantine 
hydrochloride, Amlodipine besylate and Zaleplon ODT formulation were prepared 
by direct compression method. Desloratadine, Risperidone ODT formulations were 
prepared by wet granulation technique by using taste masking ion exchange resin 
because of its bitterness taste. Amberlite was used as a taste masking agent and 
croscarmellose sodium was used as a superdisintegrant.It was concluded that all the 
formulation with improved taste masking and quick disintegration time and drug 
release achieved within the short time. 
Puttewar. T.Y et al., 2010, Formulated and evaluated orodispersible tablet of taste 
masked doxylamine succinate using ion exchange resin .To prevent bitter taste and 
unacceptable odour of the drug, the drug was taste masked with weak cation 
exchange resins like Indion-234, Indion-204 and Indion-414. Drug-resin complex 
was prepared by using batch method and effect of various processing parameters viz 
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drug-resin ratio, pH, temperature and drug concentration was optimized the loading 
conditions. A taste masking of resinate was confirmed by time intensity method and 
drug release characteristics. Doxylamine succinate Orodispersible tablets were 
prepared by direct compression method by using Crospovidone as a 
superdisintegrant.It was concluded that Crospovidone containing formulation 
exhibit lowest disintegration time and highest drug release   and so this formulation 
was considered as a best formulation. 
Dahima Rashmi et al., 2010, Formulated and evaluated taste masked 
Orodispersible tablet of Metaclopramide hydrochloride using Indion-204.The drug 
resinate complex was prepared by using Indion-204 which is used to mask the bitter 
taste of Metaclopramide HCL. The DRC was prepared by batch process. The cation 
ion exchange resin Indion-204 was selected.  The various parameters such as resin 
concentration, swelling time, stirring time, pH and temperature were optimized on 
maximum drug loading. The Orodispersible tablet of metaclopramide tablet was 
prepared by direct compression method. The dissolution studies of the tablets 
reveals that more than 85% of the drug was released within ten minutes. The 
complexation of Metaclopramide hydrochloride with Indion-204 increases the 
acceptability and palatability of formulated rapid disintegrating tablets.  
Antaryami Jena et al., 2010, Formulated and evaluated taste masked orally 
disintegrating Ondansetron hydrochloride tablet. In this study, the bitter taste of 
Ondansetron hydrochloride was masked by complexation with ion exchange resin 
indion-294.The DRC was prepared by wet granulation method. The drug-resin 
concentration was selected by maximum drug loading on resin. The ODT 
formulation of Ondansetron was prepared by wet granulation method using different 
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types of superdisintegrants like Croscarmellose sodium, Crospovidone and Indion-
234. Formulation containing Indion-234(5%) was selected as the best formulation. 
It showed less disintegration time and more drug release. 
Sukas Kakade.M et al., 2010, Formulated and evaluated mouth dissolving tablets 
of Losartan potassium by direct compression technique.In this studies, the MDT 
formulation were prepared by direct compression technique using different 
concentration of various superdisintegrants like Polyplasdone XL-10, 
Croscarmellose sodium and Explotab.The results showed that among three 
superdisintegrants ,Polyplasdone XL-10 showed less disintegration time than others. 
The reason may be high gelling tendency of Croscarmellose sodium and Explotab 
than Polyplasdone XL-10, which causes swelling tablet mass with subsequent 
retardation of disintegration. It was concluded that the relative efficiency of these 
superdisintegrants to improve the disintegration and dissolution rate of tablets was 
in the order Polyplasdone XL-10 > Croscarmellose sodium > Explotab. 
Inderbir Singh et al., 2010, Masked the unpleasant taste of Etoricoxib by 
crosslinked acrylic polymer based ion exchange resin complexation. In this study, 
the bitter taste of Etoricoxib was masked by complexation with weak cation 
exchange resin indion-234. Drug-resin complex was prepared by batch method. 1:2 
drug-resin complexes was found to be better taste masking properties .Drug-resin 
complex were evaluated by sensory taste evaluation test, FTIR and XRD analysis 
methods. The taste masked Etoricoxib tablets were prepared by direct compression 
method. The effective tablet disintegration was due to extensive swelling properties 
of the selected resins. It was concluded that complexation of Etoricoxib with cation 
exchange resin was found to increase the acceptability and palatability of the drug. 
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Raghaveendra. N.G. et al., 2010, Developed of fast dissolving carbamazepine 
tablets; effect of functionality of superdisintegrants. Carbamazepine FDT’s were 
prepared by direct compression method using different superdisintegrants such as 
CCS, CP and SSG in various concentrations. Disintegration and dissolution 
parameters decreased with increase in the level of CCS and CP, where as 
disintegrating and dissolution parameters increased with increase in the level of 
SSG in tablets. It was concluded that the formulation containing CCS (105) was 
best formulation it showed enhanced dissolution will leads to improved 
bioavailability, effectiveness and better patient compliance. 
Shankar Aulapati et al., 2010, Formulated and evaluated taste masked 
disintegrating Losartan potassium tablets. In this study, Losartan potassium fast 
disintegrating tablets were prepared by direct compression method using different 
concentration of various superdisintegrants like Crospovidone, Croscarmellose 
sodium and Sodium starch glycolate were added. The dissolution profiles showed 
that the higher concentration of crospovidone results in rapid disintegration of 
tablets in dissolution medium resulting in optimized drug release from tablet 
formulation. 
Metker Vishal et al., 2010, Formulated and evaluated orodispersible tablets of 
Lornoxicam. The orodispersible  tablet of lornoxicam were prepared by wet 
granulation technique using  Kyron T-314 as superdisintegrator and menthol as 
subliming agent .It was concluded that the sublimation method showed better 
disintegration and drug release. The rapid dissolution was due to easy breakdown of 
particles due to porous structure formation after sublimation of menthol and rapid 
absorption of drugs into the dissolution medium. The formulated orodispersible 
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tablets disintegrate within few seconds without need of water, thereby enhancing the 
absorption leading to its increased bioavailability. 
Ganesh Kumar Gudas et al., 2010, Formulated and evaluated fast dissolving 
tablets of Chlorpromazine hydrochloride. The FDT formulations were prepared by 
direct compression method. Various concentrations of five different 
superdisintegrants such as SSG, CP, CCS, L-HPC and Pregelatinised starch were 
added. Excipients like MCC, Mannitol, Aerosol, Aspartame, Magnesium stearate, 
Strawberry flavour were added to the formulation. The results showed that the order 
of enhancement of the dissolution rate with various superdisintegrants was found to 
be CP> CCS > SSG > L-HPC >Pregelatinised starch. Co-grinding of all the 
excipients before compression resulting the increase in the solubility. It was 
concluded that chlorpromazine-HCL FDT was successfully prepared with selected 
superdisintegrants in order to improve disintegrant / dissolution of drug leads to 
better patient compliance and effective therapy. 
Jeevana Jyothi .B et al., 2010, Developed fast dissolving tablets of Glibenclamide 
using Crospovidone and its kneading mixture. The fast dissolving tablets were 
prepared by wet granulation method. The kneading mixture of glibenclamide was 
prepared with Crospovidone in various concentrations. Glibenclamide-
Crospovidone (1:1.5) formulation was showed maximum amount of drug release. 
So it was selected as best formulation. 
Ashwini Madgulkar.R et al., 2009, Formulated designed and optimized novel taste 
masked mouth dissolving tablets of tramadol having adequate mechanical strength. 
This MDT formulation was prepared by direct compression technique. The 
bitterness taste of tramadol HCL was masked by making drug-resin complex with 
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Tulsion 335.A 3
2
 full factorial design and statistical models were applied to 
optimized the effect of superdisintegrant and mouth dissolving binder. It was 
concluded that the bitter taste of tramadol can be masked by forming ion exchange 
complex with tulsion335.The MDT formulation of tramadol having rapid 
disintegration and good mechanical strength achived by adding a novel combination 
of crospovidone and gelucire 39/01. 
Rajnibala et al., 2009, Developed – bitter zolpidem tartrate mouth dissolving 
tablet. The bitterness of zolpidem tartrate was masked by preparation of Drug-Resin 
comlex and Drug-Resin granules.Tulsion335 was used as a taste masking agent. 
The MDT of both resinates and granules were prepared with two different 
superdisintegrants. The MDT formulation was prepared by superdisintegrant 
addition method .Croscarmellose sodium and Crospovidone were added to the 
formulation as a superdisintegrant in various concentrations. It was concluded that 
the tablet containing Crospovidone has less disintegration time, fast and more drug 
release. 
Mahajan.K.G. et al., 2009, Formulated characterised and evaluated rapid 
disintegrating tablet of Atifloxacin sesquihydrate by ion exchange resin technique. 
In this study, the bitterness taste of Atifloxacin sesquihydrate was masked by 
Indion-204, Indion-214, Indion-234, Tulsion-335 ion exchange resins. The selection 
of drug-resin complex ratio was observed by maximum percentage of a drug 
loading on resin. The MDT     formulation was formulated by wet granulation 
method using different concentration of Sodium starch glycolate, Croscarmellose 
sodium and Crospovidone as the superdisintegrants. Formulation containing 
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Crospovidone (8%) was selected as the best formulation. It showed less 
disintegration time, good hardness, short wetting time and high drug release. 
Raval S.B et al., 2009, Formulated and evaluated tramadol hydrochloride Mouth 
dissolving tablet. The bitter taste of Tramadol hydrochloride was masked by using 
indion-294 ion exchange resin. The taste masked granules of drug   and resin were 
prepared by wet granulation method. Drug-resin ratio 1:2 showed better results than 
other drug-resin ratio .The mouth dissolving tablet of Tramadol hydrochloride was 
prepared by using direct compression method using different concentration of 
superdisintegrants like Croscarmellose sodium, Crospovidone and Indion-234. It 
was concluded that the MDT formulation containing Indion-234 (6%) as a 
superdisintegrant was the best formulation which showed the maximum percentage 
of drug release. 
Brahmenshwar Mishra et al., 2009, Fabricated and evaluated taste masked 
resinate of Risperidone and its orally disintegrating tablets. The bitter taste of 
Risperidone was masked by making Drug-Resin complex with Amberlite IRP 
64.The taste masked drug resinate was formulated by batch method. The various 
parameters were optimized like drug-resin ratio, pH medium, temperature and 
exposure time on maximum drug loading. The Risperidone Orally disintegrating 
tablet was prepared by direct compression method using Crospovidone as a 
superdisintegrant. 92% of drug release was released from the complex contained 
ODT within 5 minutes. 
Biraju Patel et al., 2009, developed and evaluated of fast dissolving tablets of 
glipizide.In this study, the glipizide FDTs were prepared by direct compression 
method. Two different superdisintegrants like Croscarmellose sodium, 
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Crospovidone were added in different concentration. Formulation containing 
Croscarmellose sodium (5%) with PVP K30 was selected as the optimized 
formulation. This formulation was compared with marketed conventional 
formulation .It was concluded that the superdisintegrant based fast dissolving tablets 
of glipizide would providing quick onset of action without need of water for 
swallowing or administration. 
Rikki Laitinen et al., 2009, Intra orally fast dissolving particles of a poorly soluble 
drug; preparation and invitro characterization. In this study, the dissolution rate of 
poorly soluble drug; perphanazine was improved by a solid dispersion 
technique.PVP K30 and PEG-8000 were selected as a carriers. Freeze drying 
method was used to preparation of solid dispersion technique. The dissolution rate 
of perphenazine was improved with all the drug polymer mixture ratio was 
compared to crystalline or micronized perphenazine.A major dissolution rate 
improvement was seen with perphenazine: PEG (1:5) formulation. It was concluded 
that the formulation of HCL salt and solid solutions promoted the dissolution of 
perphenazine. 
Raguia Ali Shoukri et al., 2009, Studied In-vitro and In-vivo evaluation of 
Nimesulide in lyophilized orally disintegrating tablets. Nimesulide, a drug with poor 
solubility and poor bioavailability was enhanced by formulating orally 
disintegrating tablet. The nimesulide orally disintegrating formulation was prepared 
by freeze drying technique. In this technique, aqueous dispersion of nimesulide, A 
sugar alcohol and a collapsed protectant with different disintegration accelerators 
were added .Results obtained from dissolution and disintegration studies showed 
that lyophilized ODT’s disintegrate within few seconds and showed significantly 
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faster dissolution rate nimesulide compared to the plain powder drug and 
commercially available immediate release nimesulide tablets. 
Jain C.P et al., 2009. Formulated and evaluated domperidone fast dissolving tablets 
.In this studies, the domperidone FDT’s were prepared by direct compression 
method using SSG as superdisintegrant such as CP,CCS and SSG. SSG swells with 
more gelling than CCS and CP, which extent disintegration time. As the 
concentration of superdisintegrants in the formulation increased in the disintegration 
time was found to decrease.SSG is disintegrates in swelling mechanism leading to 
longer wetting time. CP and CCS perform their disintegrating action by wicking 
through capillary action and fibrous structure, respectively with minimum gelling. 
In the release studies showed concentration of superdisintegrant increased the drug 
release also increased. The release rate was found to follow order; CP>CCS>SSG. 
Parmar.R.B. et al., 2009, Formulated and evaluated Domperidone fast dissolving 
tablets. In this study, the domperidone FDT was prepared by direct compression 
method using SSG as the superdisintegrant. Other excipients such as avicel PH 102, 
mannitol, lactose, talc and magnesium stearate were added and compressed into 
tablets. The best formulation was selected depends upon the disintegrating 
efficiency and rapid dissolution. The best formulation was further compared to the 
marketed preparation. It was concluded that the dissolution rate of domperidone was 
enhanced by a great extent by the addition of superdisintegrant. 
Shailendra Kumar Singh et al., 2009, Studied fast disintegrating combination 
tablets of Omeprazole and domperidone. In this study, the FDT formulation was 
prepared by direct compression method. Three various superdisintegrants such as 
kollidon-CL, Ac-Di-Sol and Sodium starch glycolate were added in different 
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concentration. Tablets prepared with Ac-Di-Sol (4.776%) had less wetting time and 
minimum water absorption ratio. In dissolution studies, the formulation containing 
Ac-Di-Sol (4.76%) showed 99% of drug release in 30 minutes. It was concluded 
that this formulation was best formulation than other formulation. 
Pushpendra Kumar. A et al., 2009, Formulated and evaluated fast dissolving 
tablets of Rupatadine fumarate. In this study, the FDT of Rupatadine fumarate was 
prepared by direct compression method. Three various superdisintegrants such as 
Ac-Di-Sol, Polyplasdone and Primojel were added in different concentration .It was 
concluded that, increase in concentration of superdisintegrants disintegration time 
decreases in the order of Ac-Di-So < Polyplasdone –XL < Primojel. Dissolution 
studies of the tablets containing Ac-Di-Sol (5%) showed rapid dissolution as 
increase the concentration of superdisintegrants. 
Ajay Banga. k. et al., 2009, Studied effects of disintegrating promoting agent, 
lubricants and moisture treatment on optimised fast disintegrating tablets. In this 
study, the effects of calcium silicate (disintegration promoting agent) and lubricants 
(magnesium stearate) on an optimized β-cyclodextrin-based fast disintegrating 
formulation. A 3
2
 full factorial design was used to optimize the concentration of 
calcium silicate and lubricant. It was concluded that 1.5% magnesium stearate 
concentration was selected as an optimum. It showed optimum hardness value with 
low disintegration time. Moisture treatment increased hardness of the fast 
disintegrating tablets. It delayed the tablets disintegration.   
Zade. P.S et al., 2009, Formulated evaluated and optimized fast dissolving tablet 
containing Tizanidine hydrochloride. In this study, the bitter taste of tizanidine 
hydrochloride was masked by complexation with Eudragit E-100 polymer. This 
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taste masked granules of drug-Eudragit E-100 were prepared by simple mass 
extrusion technique with syringe. The FDTs was prepared by direct compression 
method using different concentration of three superdisintegrants such as SSG, CCS 
and CP. Other tablets were prepared by sublimation method using camphor as a 
sublimating agent. The results showed that formulation containing crospovidone 
(5%) was selected as the optimized formulation .This formulation has the less 
disintegration time and more drug release. The tablet prepared with camphor (30%) 
was the best formulation in sublimation method. Comparison of tablets prepared by 
two methods, it was concluded that superdisintegration method was superior to 
sublimation method. 
Margret Chandira.R et al., 2008, Formulated and evaluated taste masked fast 
dissolving tablets of Ondansetron-HCL. The bitter taste of Ondansetron-HCL was 
masked by making drug-resin complex and drug-cationic polymer granules. The 
drug-resin complex was prepared with Indion-204 and drug-cationic polymer 
granules were prepared with Eudragit-E100 by time intensity method. The 
Ondansetron-HCL FDT was formulated by direct compression method using 
different superdisintegrant such as Indion-414, croscarmellose sodium in different 
concentrations. DRC formulation containing Indion-414 (2.5%) and the drug-
Eudragit E100 granules containing Indion-414 was considered as the best 
formulation .It showed less disintegration time and more drug release. 
Shagupta Khan et al., 2007, Prepared taste masked ondansetron hydrochloride 
rapid disintegrating tablets by polymer carrier system. In this study, the bitter taste 
of Ondansetron-HCL was masked by complexation with Eudragit-EPO polymer 
(amino alkyl methacrylate copolymer) .The Drug-Eudragit EPO was prepared by 
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precipitation method. Crospovidone was selected as the superdisintegrant added in 
this formulation .Micro crystalline cellulose and spray-dried mannitol (1:1) as a 
diluent and various concentration of superdisintegrants were added. The rapid 
disintegrating tablets were prepared by direct compression method. Polyplasdone 
XL-10 (7%) was selected as the optimum concentration. This showed minimal 
disintegration time. It was concluded that the FDT formulation were successively 
prepared with complete taste masking, rapid disintegration and dissolution was 
achieved. 
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CHAPTER-IV 
AIM OF WORK 
The aim of present work was an attempt to prepare bitterless fast dissolving tablet 
of desloratadine using weak cation exchange resin indion-234. 
Fast dissolving tablets are non-invasive patient friendly drug delivery systems 
which do not need water and improves pediatric and geriatric compliance. If the drug 
dissolves and getting absorbed in the mouth it may bypass enterohepatic circulation and 
prevent first pass metabolism. By this way it may improve the bio availability and dose 
related side effect of drug. Drugs which are unstable in acidic environment of stomach or 
alkaline environment of intestine can be administered by this route. Fast dissolving tablet 
should disintegrate very fast as it is administered in the oral cavity. And so, the drug release 
and onset of action acheived within short time.  
Desloradatine is chemically 8-chloro-6, 11-dihydro-1-(4-piperidinylidine-5H-benzo 
[5,6] cyclohepta[1,2-b] pyridine, which is an active descarboethoxy metabolite of 
loratadine. It is a specific, selective peripheral H1-receptor antagonist relatively non-
sedating or second generation anti-histamine. It suppresses release of histamine from 
human mast cells. 
Desloratadine is a white to off-white powder having bitter in taste. To prevent bitter 
taste, the drug was complexed with cation exchange resin like indion-204 & indion-
234(DRC). The fast dissolving tablet was prepared by direct compression method with 
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superdisintegrant like sodium starch glycolate, crospovidone, croscarmellose sodium and 
other excipients. 
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CHAPTER-V 
PLAN OF WORK 
PART-1 
PREFORMULATION STUDIES: 
a) Determination of λ-max of desloratadine in pH 5.8 and 0.1 N Hydrochloric acid. 
b) Calibration curve for the desloratadine in pH 5.8 and 0.1 N Hydrochloric acid. 
PART-2 
1) Preparation of drug-resin complex. 
2) Selection of ion exchange resin. 
PART-3 
INTERACTION STUDIES: 
1) Differential scanning calorimetric (DSC) studies 
2) Fourier Transform Infra Red Spectroscopic (FT-IR) studies  
 
PART-4 
Formulation of fast dissolving tablet of desloratadine 
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PART-5 
1) Precompression evaluation of powder blend. 
2) Post compression evaluation of prepared tablet. 
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CHAPTER-VI 
MATERIALS AND EQUIPMENTS 
 
 
MATERIALS 
 
                                           SUPPLIERS 
 
Desloratadine  
 
Enaltec Labs, Chennai, India.  
 
Indion-234 
 
Madras Pharmaceuticals, Chennai, India. 
 
Sodium starch glycolate 
 
Octis Research Lab, Uttarkhand, India. 
 
Crospovidone 
 
Octis Research Lab, Uttarkhand, India. 
 
Croscarmellose sodium 
 
Octis Research Lab, Uttarkhand, India. 
 
Microcrystalline cellulose 
 
High purity laboratory chemicals, Mumbai, India. 
   
       Mannitol 
 
Universal Scientific Appliances, Madurai, India. 
  
Saccharin sodium  
 
Universal Scientific Appliances, Madurai, India. 
  
Peppermint flavour 
 
Universal Scientific Appliances, Madurai, India. 
  
 Magnesium stearate 
 
Universal Scientific Appliances, Madurai, India. 
  
             Talc  
 
Universal Scientific Appliances, Madurai, India. 
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             EQUIPMENTS 
 
                          SUPPLIERS 
 
Electronic Weighing Balance 
 
 
A & D Company HR 200, Japan. 
 
Single Punch Tablet Compression Machine 
 
Cadmach, Ahmedabad, India. 
 
UV- Visible Spectrophotometer 
 
Shimadzu, Japan.  
  
Digital Tablet Dissolution Test Apparatus 
 
Disso 2000, Lab India, New Mumbai, India. 
  
Friability Test Apparatus 
 
 
Indian Equipment Corporation, Mumbai, India. 
India. India. 
Hot Air Oven 
 
 
              Rands Instruments, Chennai, India. 
 
Disintegration Test Apparatus 
 
Rolex, India. 
 
Tablets hardness tester (Monsanto) 
 
Pravin Enterprises, Bangalore. India. 
 
Vernier Caliper 
 
Linker, India. 
  
Magnetic stirrer 
 
 
M.C.Dalal&co, Chennai, India. 
  
Differential Scanning Calorimeter 
 
T.A.Instrument, USA. 
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CHAPTER-VII 
DRUG PROFILE 
 DESLORATADINE 
http://www.drugbank.com.,  http://www.chemblink.com 
  Synonyms  
• Descarboethoxyloratadine. 
• Descarboethoxyloratidine.  
• Desloratidine. 
Categories  
• Second generation antihistamines. 
• Cholinergic Antagonists. 
• Histamine H1 Antagonists, Non-sedating. 
Chemical Name  
   8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-
b]pyridine. 
Molecular Formula 
                            C19H19ClN2.  
   Description  
Nature - White to off white powder. 
         Solubility- Slightly soluble in water but very soluble in ethanol and propylene 
glycol. 
Molecular weight-310.8 
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Molecular Structure 
                        
PHARMACODYNAMIC PROPERTIES 
Clinical pharmacology 
Mechanism of action 
   Desloratadine competes with free histamine for binding at H1-receptor in the GI 
tract, uterus, large blood vessels and bronchial smooth muscles. This block the action of 
endogenous histamine, which subsequently leads to temporary relief of the negative 
symptoms brought on by histamine. 
PHARMACOKINETICS 
Absorption 
•  Mean peak plasma concentrations of desloratadine are reached within 3 hours. 
• Neither food nor grape fruit juice had an effect on the bioavailability of 
desloratadine.            
Distribution 
• Desloratadine is approximately 82-87% bound to plasma protein. 
• Protein binding not altered in patients with renal impairment. 
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Metabolism 
• Desloratadine is metabolized to an active metabolite,3-
hydroxydesloratadine.This metabolite subsequently undergoes glucuronidation. 
• Some individuals (7%) are slow metabolizers of desloratadine and may be 
more susceptible to dose related adverse events. 
Excretion 
• Half- life of desloratadine is 27 hours. 
• Approximately 87% excreted as metabolic products in urine and feces in equal 
proportions. 
• Desloratadine and 3-hydroxydedloratadine are poorly removed by 
hemodialysis. 
DOSAGE AND ADMINISTRATION 
• The dose of desloratadine is 5mg daily. 
• In patients with liver or renal dysfunction, a starting dose of 5mg every other 
day is recommended. 
Administration 
 Administer conventional tablets, oral solution, orally disintegrating tablets and 
fixed combination extended release tablets. 
INDICATIONS AND USES 
• Symptomatic relief of nasal and non nasal symptoms of Perennial Allergic 
Rhinitis. 
• Symptomatic treatment of Pruritus and Urticaria (hives) associated with 
Chronic Idiopathic Urticaria. 
Contraindications 
• Pharyngitis 
• Dry mouth 
• Myalgia 
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• Fatigue 
• Somnolence 
• Dysmenorrhea 
• Diarrhoea 
• Fever 
• Coughing 
• Vomiting 
• Upper Respiratory Tract infection 
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CHAPTER-VIII 
 
CROSPOVIDONE 
 
Synonyms: 
• Cross linked Povidone. 
•  Kollidon. 
•  Polyplasdone. 
•  Polyvinylpoly pyrrolidone. 
•  1-vinyl-2-pyrrolidinone homopolymer. 
 
Chemical Name: 
                  1-Ethenyl-2-pyrrolidinone homopolymer.  
Chemical Structure: 
 
                            
Empirical formula: 
             (C6H9NO)n  
 
Molecular Weight:   
 >1 000 000 
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Functional category: 
Tablet disintegrant. 
 
 Application in Pharmaceutical formulation: 
• Tablet disintegrant and dissolution agent.  
•  Solubility enhancer for poorly soluble drug. 
 
Description: 
                   Crospovidone is a white to creamy-white, finely divided, freeflowing, 
practically tasteless, odorless or nearly odourless, hygroscopic powder. 
 Stability and storage condition: 
Crospovidone is hygroscopic, it should be stored in an airtight container in a 
cool, dry place. 
 Incompatibilities: 
Crospovidone is compatible with most organic and inorganic pharmaceutical 
ingredients. When exposed to a high water level, crospovidone may form molecular 
adduct with some materials. 
 Handling Precautions: 
Observe normal precautions appropriate to the circumstances and quantity of 
material handled. Eye protection, gloves, and a dust mask are recommended. (Hand 
book of Pharmaceutical excipients-5
th
 edition, 214-216) 
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                                           CROSCARMELLOSE SODIUM 
Synonyms: 
• Ac-Di-Sol. 
•  Cross linked carboxymethylcellulose sodium. 
•  Explocel. 
•  Modified cellulose gum. 
•  Primellose. 
•  Solutab. 
•  Vivasol. 
Chemical Name: 
      Cross linked   carboxy methyl ether Cellulose sodium salt.  
Functional Category: 
Tablet and capsule disintegrant. 
Applications in Pharmaceutical Formulation: 
 Disintegrating agent for tablets and capsules. 
Description: 
-White or grayish white powder. 
-Odourless and tasteless. 
-Insoluble in water. Practically insoluble in acetone, ethanol and toluene. 
Pharmacopoeial Specifications: 
pH (1% w/v dispersion) 5.0–7.0 
Loss on drying ≤10% 
Heavy metals ≤10 ppm 
Sodium chloride and sodium glycolate	≤ 0.5% 
Sulfated ash 14.0–28.0%  
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Settling volume 10.0–30.0 ml 
Acidity/alkalinity: pH = 5.0–7.0 in aqueous dispersions. 
Density (bulk): 0.529 g/cm3  
Density (tapped): 0.819 g/cm3  
Density (true): 1.543 g/cm3  
Stability and Storage Conditions: 
Croscarmellose sodium should be stored in a well-closed container in a cool, dry 
place. 
Incompatibilities: 
 Croscarmellose sodium is not compatible with strong acids or with soluble salts 
of iron and some other metals such as aluminum, mercury, and zinc. 
Handling Precautions: 
 Croscarmellose sodium may be irritant to the eyes; eye protection is 
recommended (Hand book of Pharmaceutical excipients-5
th
 edition, 211-213). 
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                                   SODIUM STARCH GLYCOLATE 
Synonyms: 
•  Explosol. 
•  Explotab. 
•  Primojel. 
• Starch carboxymethyl ether, sodium salt. 
• Tablo. 
• Vivastar P. 
Chemical Name: 
Sodium carboxymethyl starch. 
Chemical structure: 
                       
Functional Category: 
Tablet and capsule disintegrant. 
Application in Pharmaceutical Formulation: 
• Sodium starch glycolate is  used as a disintegrant in capsule and tablet 
formulations. 
• Sodium starch glycolate is also used as a suspending vehicle. 
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Description 
• Sodium starch glycolate is a white to off-white, odorless, tasteless, free flowing 
powder 
• It does not melt, but chars at approximately 200
o
C 
• It is sparingly soluble in ethanol (95%) but practically insoluble in water. 
Pharmacopoeial Specifications: 
• Specific surface area: 0.24m2/g; 
• Swelling capacity: In water, sodium starch glycolate swells to up to 300 times 
its volume. 
• Viscosity (dynamic): 4200 mPa s (200 cP) for a 4% w/v aqueous dispersion. 
• Viscosity is 4.26 mPa s for a 2% w/v aqueous dispersion. 
Stability and Storage Conditions: 
 Sodium starch glycolate should be stored in a well-closed container in order to 
protect it from wide variations of humidity and temperature, which may cause caking. 
Incompatibilities: 
Sodium starch glycolate is incompatible with ascorbic acid. 
Handling Precautions: 
Sodium starch glycolate may be irritant to the eyes; eye protection and gloves 
are recommended. .(Hand book of Pharmaceutical excipients-5
th
 edition) 
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                                                                 INDION 234 
Description: 
INDION 234 is a high purity pharmaceutical grade weak acid cation exchange 
resin supplied as a dry powder in potassium form. It is suitable for use in 
pharmaceutical applications for tablet disintegration and taste masking of bitter drugs. 
INDION 234 is based on cross linked polyacrylic acid. 
Applications: 
Tablet disintegration 
INDION 234 is an effective tablet disintegrant which provides the necessary 
hardness and chemical stability to the tablet. The product swells up considerably (about 
300%) when in contact with water or gastro-intestinal fluids, causing rapid 
disintegration without the formation of lumps. Depending on the formulation, the use of 
0.5% to 5% of INDION 234 is recommended for effective disintegration of the tablet. 
 Some of the advantages of using INDION 234 as tablet disintegrant are: 
 Remarkable swelling tendency on wetting, causing rapid disintegration. 
 No lump formation on disintegration. 
 Compatible with commonly used therapeutic agents and excipients. 
 Works equally efficiently in hydrophilic and hydrophobic formulations. 
 Gives good mechanical strength to the tablet, 
 Facilitating easy packing and transportation. 
 Does not dissolve or have an adhesive tendency as in case of gums. 
 Does not stick to punches and dyes. 
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Characteristics properties: 
 Appearance                   –white to off-white free flowing powder.  
            
 Matrix                           -crosslinked acrylic polymer. 
 Functional Group          -carboxylic acid. 
 Ionic form as supplied   -potassium 
 Solubility                       -Insoluble in water and in common solvents. 
Specifications 
 Particle size distribution Retained on 100 BSS mesh (150 microns) ; 
1.0%,maximum 
 Retained on 200 BSS mesh (75 microns) ;70%,minimum 
 Moisture content                       ; 10%,maximum 
 Exchangeable potassium          ; 5.25 meq/dry g, minimum 
 pH of 10% slurry                     ; 7-9 
Taste masking agent 
The principle behind the technique of making a formulation tasteless with the 
help of INDION 234 is very simple and does not involve major capital investment. The 
complex is made from the drug and INDION 234. The nature of the complex is such 
that the average cation concentration of about 40 meq/I and pH of 6.7 in saliva is not 
able to break the complex 
         The complex is weak enough to be broken down by the hydrochloric acid present 
in the stomach. Thus the complex is absolutely tasteless and stable, with no after taste, 
but at the same time its bio-availability is not affected. The above technique has been 
CHAPTER-VIII                                                                       EXCIPIENT PROFILE 
 
Madurai Medical College Page 65 
 
found to be helpful in formulation of dosage forms such as dispersible tablets, chewable 
tablets, chewing gums and oral suspensions. 
Toxicity 
INDION 234 is a high molecular weight polymer. It is not absorbed by body tissue and 
is totally safe for human consumption. Tests for toxicological tolerance show that it 
does not have any pronounced physiological action at recommended dosage and is 
definitely non- toxic. Experiments on mice have shown LD 50 value for INDION 234 
to be approximately 10,000 mg/kg body weight. 
Packing 
HDPE carbouys with inner double plastic liner bags 
Storage 
INDION 234 is hygroscopic in nature. It is therefore essential to store it in a 
tightly packed container to prevent absorption of atmospheric moisture. If moisture is 
absorbed, the INDION 234 can be dried at 900 C to 1000 C for approximately 6 hours 
to reduce the moisture content below 10 (Inderbir Singh et al., 2007). 
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 Synonyms: 
• Magnesium
• Octadecano
• Stearic acid
Chemical Name: 
Octadecanoic acid
Structural Formula: 
[CH3 (CH2)16COO
Molecular Structure: 
              
Empirical Formula and
C36H70MgO4 & 59
Functional Category: 
Tablet and capsule
Application in Pharmace
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Description: 
• Magnesium stearate is a very fine, light white powder. 
• Faint odour. 
• Characteristic taste. 
• Greasy to the touch and readily adheres to the skin.  
Pharmacopoeial Specifications: 
Freezing point 5538C 
Nickel 45 ppm 
Cadmium 43 ppm 
Loss on drying 46.0% 
Chloride 40.1% 
Sulfate 41.0% 
Lead 410 ppm 
 
Stability and Storage Conditions: 
           Magnesium stearate should be stored in a well closed container in a cool, dry 
place. 
Incompatibilities: 
Incompatible with strong acids, alkalis, and iron salts. Avoid mixing with strong 
oxidizing materials. Magnesium stearate cannot be used in products containing aspirin, 
some vitamins, and most alkaloidal salts. 
Safety: 
Oral consumption of large quantities may produce a laxative effect or mucosal 
irritation.  
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Handling Precautions: 
- Eye protection and gloves are recommended. 
-Excessive inhalation of magnesium stearate dust may cause upper respiratory 
tract discomfort, coughing, and choking. .(Hand book of Pharmaceutical excipients-5
th
 
edition,430-433)  
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Synonyms: 
• Cordycepic
•  Manna sug
• D-Mannite
•  Pearlitol.
Chemical Name:  
D-Mannitol. 
Chemical structure: 
  
Empirical Formula and
C6H14O6 & 182.17
Functional Category: 
• Diluent. 
•  Sweetenin
•  Tonicity 
Application in Pharmace
• Mannitol 
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• Mannitol is commonly used as an excipient in the manufacture of 
chewable tablet formulations. 
•  Plasticizer in soft-gelatin capsules, as a component of sustained-release 
tablet formulation. 
• It is used as a carrier in dry powder inhalers. 
• It is also used as diluents in rapidly dispersing oral dosage forms. 
• It is used in food applications as a bulking agent. 
 
Description: 
• Mannitol is a white, odorless, crystalline powder, or free-flowing 
granules. 
• It has a sweet taste. 
•  Microscopically, it appears as orthorhombic needles when crystallized 
from alcohol. 
•  Mannitol shows polymorphism.  
                            Pharmacopoeial Specifications: 
• Density (bulk):0.430 g/cm3. 
• Density (tapped):0.734 g/cm3. 
• Density (true): 1.514 g/cm3. 
• Dissociation constant: pKa = 13.5 at 188C. 
• Flowability: powder is cohesive, granules are free flowing. 
• Melting point: 166–168
o
C 
• Loss on drying:  40.3%  
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Stability and Storage Conditions: 
 It should be stored in a well-closed container in a cool, dry place. 
Incompatibilities: 
• Mannitol solutions, 20% w/v or stronger, may be salted out by potassium 
chloride or sodium chloride. 
•  Mannitol is incompatible with xylitol infusion and may form complexes 
with some metals such as aluminum, copper, and iron. 
•  Reducing sugar impurities in mannitol have been implicated in the 
oxidative degradation of a peptide in a lyophilized formation.  
Handling Precautions: 
Mannitol may be irritant to the eyes; eye protection is recommended. . (Hand 
book of Pharmaceutical excipients-5
th
 edition,449-453) 
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                            MICROCRYSTALLINE CELLULOSE 
Synonyms: 
• Avicel PH. 
•  Celex. 
•  Celphere. 
•  Ceolus KG. 
•  Ethispheres. 
•  Fibrocel. 
•  Pharmacel. . 
•  Vivapur. 
Chemical Name: 
Cellulose. 
Empirical Formula: 
(C6H10O5) n  
Molecular Weight: 
36 000 
Functional Category: 
• Adsorbent. 
•  Suspending agent, Tablet and capsule diluents, tablet disintegrant. 
Application in Pharmaceutical Formulation: 
• Microcrystalline cellulose is used as a binder/diluent in oral tablet and 
capsule formulations.  
• Microcrystalline cellulose is used as a lubricant and disintegrant agent in 
tablet formulation. 
• Microcrystalline cellulose is also used in cosmetics and food products.  
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Description: 
Microcrystalline cellulose is a white, odorless, tasteless, crystalline powder 
composed of porous particles.  
                                              Use Concentration (%) 
• Adsorbent: 20–90 
• Antiadherent: 5–20 
• Capsule binder/diluent: 20–90 
• Tablet disintegrant : 5–15 
• Tablet binder/diluents: 20–90 
Pharmacopoeial Specifications: 
• pH: 5.0–7.0  
• Loss on drying: 47.0%  
• Residue on ignition: 40.05% 
• Sulfated ash: 40.1% 
• Heavy metals: 410 ppm  
Typical Properties: 
• Density (tapped):0.478 g/cm3, 
• Density (true): 1.512–1.668 g/cm3 
• Flowability: 1.41 g/s for Emcocel 90M. 
• Melting point: chars at 260–2708C. 
• Microcrystalline cellulose is hygroscopic. 
Stability and Storage Conditions: 
Microcrystalline cellulose is a stable though hygroscopic material. The bulk 
material should be stored in a well-closed container in a cool, dry place. 
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Incompatibilities: 
Microcrystalline cellulose is incompatible with strong oxidizing agents. 
Handling Precautions: 
 Microcrystalline cellulose may be irritant to the eyes. Gloves, eye protection, 
and a dust mask are recommended. .(Hand book of Pharmaceutical excipients-5
th
 
edition132-135, ) 
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                      SACCHARIN SODIUM    
 
Synonyms: 
                      1,2-Benzisothiazolin-3-one 1,1-dioxide, sodium salt; Crystallose E954; 
sodium o-benzosulfimide; soluble gluside; soluble saccharin; sucaryl sodium. 
 
Chemical Name; 
1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt  for the dihydrate 
 for the anhydrous material. 
 
Chemical structure: 
                      
Empirical Formula and Molecular Weight: 
C7H4NNaO3S 205.16 
Functional Category: 
Sweetening agent. 
Application in Pharmaceutical Formulation: 
                               Saccharin sodium is an intense sweetening agent used in beverages, 
food products, table-top sweeteners and pharmaceutical formulations such as tablets, 
powders, medicated confectionery, gels, suspensions, liquids, and mouthwashes; It is 
also used in vitamin preparations. 
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  Uses of saccharin sodium 
• Dental paste/gel 0.12–0.3% 
• IM/IV injections 0.9% 
• Oral solution 0.075–0.6% 
Description: 
                        Saccharin sodium occurs as a white, odorless or faintly aromatic, 
efflorescent, crystalline powder. It has an intensely sweet taste, with a metallic 
aftertaste that at normal levels of use can be detected by approximately 25% of the 
population. Saccharin sodium can contain variable amounts of water. 
 
Pharmacopoeial Specification: 
• Water 415.0%  
• Arsenic 42 ppm 
• Selenium 40.003% 
• Heavy metals 420 ppm  
• Assay (anhydrous basis) 99.0–101.0%  
 
• Typical Properties: 
• Acidity/alkalinity: pH = 6.6 (10% w/v aqueous solution) 
• Density (bulk):0.8–1.1 g/cm3  
• Density (particle): 1.70 g/cm3 
• Density (tapped): 0.9–1.2 g/cm3  
• Moisture content: 14.5% w/w water;  
• Solvent Solubility at 208C 
• Specific surface area: 0.25m2/g                
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Stability and Storage Conditions: 
              Saccharin sodium is stable under the normal range of conditions employed in 
formulations. Saccharin sodium should be stored in a well-closed container in a cool, 
dry place. 
 
Handling Precautions: 
               Observe normal precautions appropriate to the circumstances and quantity of 
material handled. Eye protection and a dust mask are recommended. .(Hand book of 
Pharmaceutican excipients-5
th
 edition) 
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                                                            TALC 
Synonyms: 
Altalc, E553b, hydrous magnesium calcium silicate, hydrous magnesium 
silicate, Luzenac Pharma, magnesium hydrogen metasilicate, Magsil Osmanthus, 
Magsil Star, powdered talc, purified French chalk, Purtalc, soapstone, steatite, 
Superiore. 
Chemical Name: 
Talc  
Empirical Formula: 
 Mg6(Si2O5)4(OH)4. 
Chemical Structure: 
                          
Functional Category: 
Anticaking agent, glidant, tablet and capsule diluent, tablet and capsule 
lubricant. 
Applications in Pharmaceutical Formulations: 
 Lubricant and diluents. 
 Dissolution retardant in the development of controlled-release products. 
 An adsorbant. 
 Dusting powder. 
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  Talc is additionally used to clarify liquids and is also used in cosmetics and 
food products, mainly for its lubricant properties. 
                                           Dusting powder: 90.0–99.0% 
                                           Glidant and tablet lubricant: 1.0–10.0% 
                                            Tablet and capsule diluents: 5.0–30.0% 
Description: 
Talc is a very fine, white to grayish-white, odorless, impalpable, unctuous, 
crystalline powder. It adheres readily to the skin and is soft to the touch and free from 
grittiness. 
Pharmacopoeial Specifications: 
 Acidity/alkalinity: pH = 7–10 for a 20% w/v aqueous dispersion. 
 Hardness (Mohs): 1.0–1.5 
 Solubility: practically insoluble in dilute acids and alkalis, organic 
solvents, and water. 
 Specific gravity: 2.7–2.8 
 Specific surface area: 2.41–2.42m2/g 
Stability and Storage Conditions: 
Talc is a stable material and may be sterilized by heating at 1608C for not less 
than 1 hour. It may also be sterilized by exposure to ethylene oxide or gamma 
irradiation.Talc should be stored in a well-closed container in a cool, dry place. 
Incompatibilities: 
Incompatible with quaternary ammonium compounds. 
Handling Precautions: 
 Talc is irritant if inhaled and prolonged excessive exposure may cause 
pneumoconiosis. In the UK, the occupational exposure limit for talc is 1 mg/m3 of 
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respirable dust long-term (8-hour TWA).Eye protection, gloves, and a respirator are 
recommended (Handbook of Pharmaceutical excipients- 5
th
 edition, 641-643). 
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CHAPTER-IX 
EXPERIMENTAL DETAILS 
I. CALIBRATION OF DESLORATADINE IN pH5.8 
a) Preparation of pH 5.8 Buffer Solution: 
 Add 50ml of 0.2M potassium dihydrogenortho phosphate in a 200ml of 
volumetric flask. Add 3.6ml of 0.2M Sodium hydroxide is added and made upto the 
volume with distilled water. 
 
b) Calibration curve of Desloratadine in pH 5.8: 
An accurately weighed quantity (100mg) of pure Desloratadine is dissolved in 
sufficient amount of methanol and made upto 100ml with methanol to produce 1mg/ml 
solution. From this 10ml of the solution is pipetted-out and made upto 100ml with the 
pH 5.8 buffer solution.From this 2-20ml are pipetted-out and diluted to 100ml with the 
pH 5.8 buffer solution. The solution is scanned within the range of 200-400 nm in UV-
Spectrophotometer.Theabsorbance of the solutions is measured at the λmax.The 
calibration graph is drawn by taking concentration in X-axis and respective absorbance 
in Y-axis to get a straight line as per Beers law. 
 
II. CALIBRATION OF DESLORATADINE IN 0.1N HYDROCHLORIC ACID 
a) Preparation of 0.1N Hydrochloric Acid Buffer Solution: 
Dilute 8.5ml of hydrochloric acid in distilled waterand the volume is made up to 
1000 ml. 
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b) Calibration Curve of Desloratadine in 0.1N Hydrochloric Acid: 
An accurately weighed quantity (100mg) of pure Desloratadine is dissolved in 
sufficientamount of methanol and made upto 100ml with methanol to produce 1mg/ml 
solution. From this 10ml of the solution is pipetted-out and made upto 100ml with the 
0.1N Hydrochloric acid buffer solution. From this 2-20ml arepipetted-out and diluted to 
100ml with the 0.1N Hydrochloric acid buffer solution.The solution is scanned within 
the range of 200-400 nm in UV-Spectrophotometer. The absorbances of the solutions 
are measured at the λmax.The calibration graph is drawn by taking concentration in X-
axis and respective absorbance in Y-axis to get a straight line as per Beers law. 
 
III. PREPARATION OF DRUG-RESIN COMPLEX(DRC) 
The drug and resin are passed through a #40 mesh screen prior to mixing.The 
drug desloratadine is dispersed in purified water (100ml) under stirring by using 
magnetic stirrer at 100rpm in room temperature (25-27˚C).The pH of the drug 
dispersion is adjusted to pH 6.5 ±0.5 with 2% W/V citric acid solution. The resin is 
thenadded to the pHadjusted drug dispersion and stirred for 3 hours.The drug resinate 
dispersion is filtered through whatmann filter paper No;41 and dried at 60˚C.The dried 
mass is passed through #24 mesh.(Venkata Ramana Retty.S et al., 2010) 
 
IV. SELECTION OF ION-EXCHANGE RESIN(IER) 
The DRC is prepared with two different resins viz INDION-204 and INDION-
234.In each case, 100mg of Desloratadine in deionised water is stirred with resin 
containing various drug-resin ratios(1:1, 1:2, 1:3, 1:4, 1:5) by using magnetic stirrerand 
stirred for 3 hours at 100 rpm in room temperature.Then the dispersion is filtered 
through Whatmann filter paper No; 41.The amount of drug loaded is determined 
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indirectly by estimating the amount remaining to be loaded in solution 
spectrophotometrically at 242 nm in UV-Spectrophotometer. Theresin to which the 
drug bound to the maximum percentageis selected for further studies. The following 
formula is used to calculate the percentage of drug bound to resin. 
             (Total amount of drug) – (unbound drug) 
%Drug Bound to Resin=    -------------------------------------------------      X100. 
(Total amount of drug) 
 
V. EVALUATION OF DRUG RESIN COMPLEX 
a) Fourier Transform-Infra Red (FT-IR)Studies:  
                 Desloratadine,indion-234 and DRC are subjected to Fourier Transform Infra 
Red Spectroscopy studies (Shimadzu,Japan).Samples are prepared using KBr disc 
method and spectra are recorded over the range 400-4000 per cm.Spectra are analyzed 
for drug-resin interaction and functional groups involved in the complexation process. 
b) Differential Scanning Colorimetric(DSC) studies: 
 A Differential Scanning Calorimeter (DSC Q200 V24.4 Build 116) is used. The 
equipment is calibrated using indium and zinc. Samples are heated at 10°C per minute 
in aluminium pans under Nitrogen atmosphere. The onset of the melting points and 
enthalpies of fusion are calculated. The cell had a nitrogen purge flowing approximately 
at 30 cube cm per minute. The cell and sample are held isothermally at 79°C for 30 
minutes to purge the headspace and sample with nitrogen before heating. The cell and 
sample are then heated to 400°C while monitoring heat flow. 
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VI. FORMULATION OF FAST DISSOLVING TABLET OF DESLORATADINE 
An accurately weighed quantity of drug-resin complex is mixed with different 
ratio of (1.5%, 3%, 4.5%, 6%, 7.5%) superdisintegrant (Sodium starch glycolate, 
Crospovidone, Croscarmellose Sodium). The drug-resin complex along with 
superdisintegrant is mixed with Microcrystalline cellulose, Mannitol, Saccharin sodium 
and Peppermint flavour in geometrical dilution. Then Magnesium stearate and Talc are 
added, mixed and compressed into tablets using single punch tablet punching machine 
to produce flat faced tablets weighing 200mg each with 8mm diameter. The 
compositions of the different formulation are given in Table-5. (Sona P.S. et al., 2011) 
VII. PRECOMPRESSION EVALUATION FOR POWDER BLEND 
i. Angle of Repose: 
                The flow characteristics are measured by angle of repose. Angle of repose is 
defined as the maximum angle possible between the surface of a pile of the powder and 
the horizontal plane. 
tan	=h/r 
 =tan
-1
(h/r) 
Where, 
            h=Height of the pile. 
             r=Radius of the base of the pile. 
														=Angle of repose. 
                The angle of repose is determined by fixed funnel method. The powder mass 
is allowed to flow through the funnel kept on a stand at a fixed height. The powders are 
carefully poured through the funnel on the piece of paper placed on the horizontal 
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surface until the apex of conical pile just reached the tip of the funnel. The height of the 
pile and radius of the conical pile is noted and the angle of repose is calculated by the 
above said formula. (Priyanka Nagar et al., 2011) 
ii. Bulk Density: 
Bulk density is defined as the mass of the powder divided by the bulk volume;it 
is expressed as gm/cm
3
. A powder blend (10g) is carefully  introduced into a 100ml 
graduated cylinder .The cylinder is dropped onto a hard wood surface three times from 
a height of 1 inch at two second interval. The bulk density obtained by dividing the 
weight of samples in gm by final volume in cm
3 
(Mukesh.P.Ratnaparkhi et al., 2008). 
                            Mass of powder                           m 
Bulk density= ------------------------------        = -------------- 
                            Bulk volume            Vb 
 
iii. Tapped Density: 
             Tapped density is determined by placing a graduated cylinder, containing a 
known mass of a drug-resinate excipients blend. The cylinder is allowed to fall under its 
own weight onto a hard surface from the height of 10cm at 2 second intervals.The 
tapping is continued until no further change in volume is noted.(Rajashree Panigrahi et 
al., 2010). 
The tapped density (Dt) is calculated in g/ml by the formula                                            
                                       Dt = m/Vt 
Where,             
  m=Weight of the sample powder taken. 
   Vt=Tapped volume.  
CHAPTER- IX                                                         EXPERIMENTAL DETAILS 
 
Madurai Medical College Page 86 
 
iv. Carr’s Compressibility Index: 
           The simplex way of measurement of the free flow of powder is 
compressibility.(Suhas.M.Kakade et al., 2010) Which is calculated by the following 
formula, 
               Tapped density-Bulk density 
Compressibility Index   =         -------------------------------------------- X 100             
         Tapped density 
v. Hausner’s Ratio: 
Hausner’s ratio is an indirect index of ease of powder flow. If the Hausner’s 
ratio of the powder is near to 1.25 indicates better powder flow.(Kuldeep V et al., 
2010). It is calculated by the following formula, 
                                       Tapped density 
Hausner’s ratio      =        --------------------------- 
                                      Bulk density 
 
< 1.25-good flow. 
1.25-poor flow. 
vi. Drug Content:    
 5mg equivalent of DRC is stirred with 100ml of 0.1N Hydrochloric acid for 60 
minutes so as to release the entire drug from DRC. The mixture is filtered and diluted to 
100ml using 0.1N Hydrochloric acid. The absorbance of the solution is measured at 
242nm using 0.1 N Hydrochloric acid as blank and the content of desloratadine is 
estimated (Dahima Rashmi et al., 2010). 
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VIII. POST COMPRESSION EVALUATION  
i. Thickness and Diameter: 
          Tablet thickness and diameter is an important characteristic of the tablets.In 
reproducing appearance and also in counting by using filling equipment. The thickness 
and diameter of the fast dissolving tablets are determined by using vernier calliper 
(Magesh Kumar.K et al., 2009). 
ii. Hardness: 
           The hardness of the tablet is indicative of its tensile strength and is measured in 
terms of load/pressure required to crush it when placed on its edge.The hardness is a 
function of physical properties of granules like their hardness and deformation under 
load, binders and above all the compression force. The hardness has influence on 
disintegration and dissolution times and is as such a factor that may affect 
bioavailability. The hardness of the tablet is determined by using Monsanto hardness 
tester. (Puttewar T.Y et al., 2010) 
iii. Weight Variation Test: 
            The weight variation test is carried out in order to ensure uniformity in the 
weight of tablets in a batch. First the total weight of 20 tablets from each formulation is 
determined and the average is calculated. The individual weight of the each tablet is 
also determined to find out the weight variation. The tablets meets the USP test , If no 
more than 2 tablets are outside the percentage limit and if no tablet differs by more than 
2 times the percentage limits.(Priyanka Nagar et al., 2011) 
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USP specification for the uniformity of weight 
S.No. Average weight(mg) Maximum % difference allowed 
1 130 or less 10% 
2 130-324 mg 7.5% 
3 More than 324 mg 5% 
 
iv. Friability: 
              Friability is determined using Roche friabilator.10 tablets from each 
formulation are accurately weighed and placed in the drum of friabilator.The tablets are 
rotated at 25 rpm for a period of 4 min and then removed,dedusted and accurately 
reweighed. The percentage loss in weight is calculated and taken as a measure of 
friability. The weight loss should not be more than 1 %.( Raguia Ali Shoukri et al., 
2009) 
                                         Initial weight-Final weight 
Percentage friability=     ………………………………..      X 100 
    Initial weight 
v. Uniformity of Content: 
            Ten tablets are selected randomly and powdered them. The average weight is 
calculated .The average weight of the tablet powder  is dissolved in 100ml of 0.1N 
Hydrochloric acid,stirred for 60 minutes by using  magnetic stirrer at 100rpm 
maintained at room temperature. The dispersion is filtered and collect the filtrate .One 
ml of filtrate is diluted to 100ml with 0.1N Hydro chloric acid. The absorbance of this 
solution is measured at 242 nm using 0.1N Hydro chloric acid as blank and content of 
desloratadine is estimated (Ashwini R.Madgulkar et al., 2009). 
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vi. Wetting Time:  
Ten millilitres of distilled water containing Methylene blue,water soluble dye is 
placed in a petridish of 10cm diameter.Tablets are carefully placed in the centre of the 
petridish and the time required for water to reach the upper surface of the tablet is noted 
as the wetting time. Three tablets are selected and the average wetting time is 
calculated.(Raguia Ali Shoukri et al., 2009) 
vii. Water Absorption Ratio: 
 A piece of tissue paper folded twice is kept in a petridish containing 6ml of 
purified water .The tablet is placed on the tissue paper and allowed to wet completely. 
The wetted tablet is removed and reweighed(Sukash M.Kakade et al., 2010).Water 
absorption ratio (R) is determined according to the following equation 
Wa-Wb 
R=      -------------- X 100 
Wb 
 
Where, 
Wb-Weight of the tablet before water absorption. 
Wa-Weight of the tablet after water absorption. 
viii. In-Vitro Disintegration Time: 
            The disintegration time is defined as the time necessary for the Fast 
disintegrating tablet to completely disintegrate until no solid residue remains or only a 
trace amount of soft residue remains on the screen. Disintegration time is measured in 
900 ml artificial saliva (pH 5.8), according to the USP 24 method without disc at 
37	±0.5℃	. The disintegration time of 3 individual tablets are recorded and the average 
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is reported.As per the European Pharmacopoeia (EP), the orodispersible tablets should 
disintegrate within 3 minutes (C.P.Jain et al., 2009). 
ix. In-Vitro Dissolution Test: 
The release rate of desloratadine from the fast dissolving tablet is determined using 
dissolution testing apparatus type -1(paddle method). The dissolution test is performed 
using 900ml of 0.1N HCL, at 37 ±0.5℃and 50 rpm.A sample (5ml) of the solution is 
withdrawn from the dissolution apparatus at 5,10,15,20,25,30 min.The samples are 
replaced with fresh dissolution medium of same quantity.The absorbance of these 
solutions is measured at 242 nm in UV-Spectrophotometer(Parmar R.B et al., 2009). 
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CHAPTER-X 
RESULTS AND DISCUSSION 
I. CALIBRATION OF DESLORATADINE IN pH 5.8 
The λmax of desloratadine was determined by scanning the 10µg/ml solution of 
the drug in buffer solution of pH 5.8 using UV-Spectrophotometer and was found to be 
242nm. A standard calibration curve for the drug was obtained by measuring   
absorbance at 242 nm and by plotting the graph of absorbance Vs concentration. The 
calibration plots of desloratadine were shown in Table-1and Figure-1. The linear 
correlation co-efficient was found to be  =0.9997. Desloratadine obeys Beer’s law 
within the concentration range of 2-20 µg/ml. 
II. CALIBRATION OF DESLORATADINE IN 0.1N HYDROCHLORIC ACID 
The λmax of desloratadine was determined by scanning the 10µg/ml solution of 
the drug in buffer solution of 0.1N Hydrochloric acid using UV-Spectrophotometer and 
was found to be 242 nm. A standard calibration curve for the drug was obtained by 
measuring   absorbance at 242 nm and by plotting the graph of absorbance Vs 
concentration. The calibration plots of desloratadine were shown in Table- 2 and 
Figure- 2. The linear correlation co-efficient was found to be  =0.9996. Desloratadine 
obeys Beer’s law within the concentration range of 2-20 µg/ml. 
 
III. PREPARATION OF DRUG RESIN COMPLEX (DRC) 
The DRC was prepared with two different resins viz Indion-204 and Indion-234. 
From the trial, it was found that the Indion-234 resin had maximum percentage drug 
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bound to resin. And so, Indion-234 was selected for the preparation of drug resin 
complex. The results were shown in Table-3&4. (Venkada Ramana Retty.S et al., 2010) 
 
IV. SELETION OF ION EXCHANGE RESIN (IER) 
 From the trial, the complex which had maximum quantity of drug loading was 
selected for further studies. It was found that the maximum percentage drug bound to 
resin  for the Indion-204 is 65.53 ± 2.54 % at the ratio of 1:5 and 88.19 ± 0.68 % of 
drug bound to resin for Indion-234 at the ratio of 1:5. And so, Indion-234 was selected 
as the best   resin for formulating drug-resin complex. The results were shown in Table-
3&4 (Venkata Ramana Retty.S et al., 2010) 
 
V. EVALUATION OF DRUG RESIN COMPLEX 
a) Fourier Transform-Infra Red (FT-IR)Studies: 
The Fourier Transform Infra Red Spectroscopy studies were carried out for pure 
drug, resin, physical mixture of drug-resin and drug-resin complex. The spectra were 
shown in Figure-3.The spectral analysis of pure drug  showed the characteristics peaks 
at 3423.76cm-
1 
, 3325.39cm-
1
, 1327.07cm-
1
, 1292.35cm-
1
, 844.85 cm-
1
, 773.48 cm
-1
. 
All the above characteristic peaks appear in the spectra of all samples were within the 
same wavelength number. This indicates that there were no interactions between the 
drug and resin. 
b) Differential Scanning Colorimetric (DSC) Studies: 
The DSC thermograms of pure drug, resin, drug-resin complex were shown in 
the Figure-4. An endothermic peak corresponding to the melting point of pure drug was 
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prominent in the drug-resin complex which suggested clearly that there was no 
interaction between drug, resin and drug-resin complex 
VI. FORMULATION OF FAST DISSOLVING TABLET OF DESLORATADINE 
The fast dissolving tablet of Desloratadine was prepared by direct compression 
method using different ratio (1.5%, 3%, 4.5%, 6%, and 7.5%) of superdisintegrants 
(Sodium starch glycolate, Crospovidone and Croscarmellose sodium).The composition 
of the different formulation were given in Table-5. 
Fifteen formulations (F1-F15) were prepared. All the tablets were light pink 
colour and round in shape having 8 mm diameter. 
VII. PRECOMPRESSION EVALUATION FOR POWDER BLEND 
i. Angle of Repose: 
The angle of repose was used to determine the flow properties of powder blend. 
The angle of repose of all the formulations ranged from 28˚.35’ to 31˚.79’. The results 
indicated that all the formulations exhibited good flow properties. The results of angle 
of repose for all the formulations were shown in Table-6. 
ii. Bulk density: 
The bulk density was used to determine the free flowing properties of powder 
blend.  The bulk density of all the formulations was in the range of 0.47 - 0.52 g/cm
3.
 
The values of bulk density showed that the blend was not tightly packed and indicated 
good flow properties. The results of bulk density for all the formulations were shown in 
Table-6. 
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iii. Tapped Density: 
The tapped density was used to access the free flowing properties of powder 
blend. Table tapped density of all the formulations were in the range of 0.52 - 0.59 
g/cm
3
. The results indicated that the blends of all the formulation had good flow 
properties. The results of tapped density for all the formulations were shown in Table-6. 
iv. Carr’s Compressibility Index: 
 The carr’s compressibility index was used to access the free flowing properties 
of powder blend..The compressibility index of all the formulations ranged from 9.98 -
15.78 %. This value below 15% indicates a powder having good flow property and 
good propensity of compression. The results of compressibility for all formulations 
were shown in Table-6. 
v. Hausner’s Ratio: 
The Hausner’s ratio was an indirect index of ease of powder flow. The 
Hausner’s ratio of all the formulations ranged from 1.11-1.18. It was less than 1.25 
indicated better flow property of blend. The results of Hausner’s ratio for all the 
formulations were shown in Table-6. 
vi. Drug Content: 
The drug content of the tablets was used to ensure the therapeutic dosage of the 
active ingredient in the formulation. The drug content of all the formulation was in the 
range of 97.04 – 101.49%. The results indicated all the formulations were within the 
acceptable limits as per USP. The results were shown in Table-6. 
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VIII. POST COMPRESSION EVALUATION 
The prepared tablets were evaluated on various parameters such as thickness and 
diameter, hardness, weight variation, friability, uniformity content, wetting time, water 
absorption ratio, In-vitro disintegration time and In-vitro dissolution test. The results 
were summarized in Table-7. 
i. Thickness and Diameter: 
The thickness and diameter of all the formulations were used to determine the 
uniformity of size and shape of the tablets. From the results it was found that the 
thickness of the tablet in all formulation was 3mm and the diameter of the tablet in all 
formulation was 8mm.The results indicating all the formulations had uniform size and 
shape. The results were shown in Table-7. 
ii. Hardness: 
The hardness of the tablets was used to determine the resistance capacity of the 
tablets to chipping, abrasion or breakage under conditions of storage, transportation and 
handling before usage. The hardness of the tablets of all the formulations was found to 
be 3kg/cm
2
. The result indicated that all the tablets had a good mechanical strength. The 
results   of the hardness for all the formulations were shown in Table-7. 
iii. Weight Variation Test: 
The weight variation test was used to ensure the uniformity of the tablet in all 
formulations. The weight of all the tablets from each formulation was in the range from 
178.52 - 207.46 mg to 204.12 - 237.2 mg. It was found all the tablets passed weight 
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variation test, as the percentage weight variation was within the acceptable limits of 
7.5%. The results were shown in Table-7. 
iv. Friability: 
Friability test was measured to ensure the mechanical strength of tablet. The 
results showed that the friability of all the formulation was ranged from 0.36 % to 0.9 
%. Friability of all the formulation was lesser than 1 % which indicated the tablets had a 
good mechanical resistance. The results were shown in Table-7. 
v. Uniformity of Content:  
The uniformity content test was used to determine the uniform amount of active 
ingredient present in all formulations. The drug content in the content uniformity of all 
the formulations was found to be in the range of 95.56 % - 101.23 %. The results 
indicated all the formulations were within the acceptable limits as per USP limits. The 
results were shown in Table-7. 
vi. Wetting Time: 
Wetting time of the tablet was used to assess the capacity of the tablets to 
disintegrate by swelling of water. All the formulations showed quick wetting, this may 
be due to ability of swelling and also capacity of absorption of water. The results of 
wetting time of all the formulations were shown in Table-7. 
 The formulations  F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11, F12, F13, F14, 
F15 showed the wetting time 47, 56, 40, 35, 27, 26, 14, 8, 8, 5, 17, 16, 17, 14, 11 
seconds respectively. The results indicated that as the concentration of superdisintegrant 
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increased wetting time was decreased. Formulation F10 containing Crospovidone 
(7.5%) shows lesser wetting time than other formulation. 
This may be due to fact that Crospovidone and Croscarmellose sodium perform 
their disintegrating action by wicking through capillary action and fibrous structure 
respectively with minimum gelling.Sodium starch glycolate is disintegrated by swelling 
mechanism leading to longer wetting time. (N.G.Raghavendra Rao et al., 2010) 
.Water Absorption Ratio: 
 The water absorption ratio test was used to ensure the capacity of the 
superdisintegrant to absorb the water. The results of water absorption ratio of all the 
formulation were shown in Table-7. 
Formulations F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11, F12, F13, F14, F15 
showed the water absorption ratio 55.26%,59.07%,68.60%,75.13%, 86.27%, 63.91%, 
72.82%, 80.71% 88.27%, 91.71%, 69.97%, 77.65% 78.17%, 82.05%, 83.92% The 
results showed that,as concentration of superdisintegrant increased water absorption 
ratio was also increased. Formulation F10 containing Crospovidone shows highest 
water absorption ratio (91.71%) than other formulation. 
The reason for high water absorption ratio for Crospovidone may be due to 
highly porous structure, it draws large amount of water by water wicking mechanism 
into porous network of tablet resulting rapidly absorbs water into its network, and 
highest than formulation prepared with other superdisintegrants.   It was indicated that 
water absorption ratio increased with decrease in wetting time. (Arvind S.Singh et al., 
2010) 
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vii. In-Vitro Disintegration Time: 
 The In- vitro disintegration time was determined by disintegration test 
apparatus. Formulations F1, F2, F3, F4, F5, F6, F7, F8, F9, F10, F11, F12, F13, F14, 
F15 showed the  disintegration time 48, 47, 44, 30, 20, 23, 16, 10, 8, 6, 15, 13, 14, 11, 
10 seconds respectively. It was observed that Formulation F10 containing 
Crospovidone (7.5%) containing tablet disintegrate rapidly in a short time (6 
seconds).The results of disintegration of all the tablets were found to be lesser than1 
min and so satisfied the criteria of fast dissolving tablets. The results were shown in 
Table-7. 
 The faster disintegration time of Crospovidone tablets may be attributed to its 
rapid capillary activity and pronounced hydration with little tendency to gel formation. 
Thus these results suggest that the disintegration times can be decreased by using 
wicking type of disintegrants (Ajay Kumar Patil et al., 2011). 
viii. In-vitro Dissolution Studies: 
The results of In-vitro drug release studies from fast dissolving tablets of 
desloratadine were shown in the Table-7 .Figure5, 6, 7, and 8. 
             The results showed that the release profiles of different formulations varied 
according to the type of superdisintegrants and its percentage to the formulations. 
Maximum percentage of drug (More than 90%) was released from the all formulations 
within 10 minutes.  
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Effect of Superdisintegrant on Drug Release: 
The formulations  F1, F2, F3, F4, F5 were prepared with 1.5% , 3% , 4.5% , 6% 
, 7.5%  Sodium starch glycolate as a superdisintegrant, showed the cumulative 
percentage of drug release 95.82%,  95.75%, 96.42%, 91.83%, 92.19% respectively at 
10 minutes. Formulation F3 containing 4.5% Sodium starch glycolate shows maximum 
drug release (96.42 %,) at 10 minutes.  This result indicated that the optimum 
concentration of Sodium starch glycolate was 4.5%. 
             The formulation F6, F7, F8, F9, F10 were prepared with 1.5% , 3% , 4.5% , 6% 
, 7.5% Crospovidone as a superdisintegrant, showed the cumulative percentage of drug 
release 96.68% , 94.54% , 93.48% , 96.55% , 97.12% respectively at 10 
minutes.Formulation F10 containing 7.5% Crospovidone shows maximum drug release 
(97.12 %,) at 10 minutes. This result indicated that the optimum concentration of 
Crospovidonewas 7.5% 
           The formulation F11, F12, F13, F14, F15 were prepared with 1.5% , 3% , 4.5% , 
6% , 7.5% Croscarmellose sodium as a superdisintegrant, showed the cumulative 
percentage of drug release 90.95% , 91.55% , 93.43% , 95.09% , 93.71% respectively at 
10 minutes .Formulation F14 containing 6% Croscarmellose sodium shows maximum 
drug release (95.09 %,) at 10 minutes.  This result indicated that the optimum 
concentration of Croscarmellose Sodium was 6%. 
From the results, the release rates of superdisintegrants were in the order:  
              Crospovidone > Sodium starch glycolate > Croscarmellose sodium 
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  The maximum percentage of drug release was achieved by the formulation 
containing Crospovidone (7.5%) as a superdisintegrant.  It may be due to the results in 
the rapid disintegration of tablet in dissolution medium resulting in maximum drug 
release. Among fifteen formulations, formulation 10 (F-10) was selected as a best 
formulation because of its lowest disintegration time and highest drug release.(C.P.Jain 
et al., 2009) 
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TABLE: 1 CALIBRATION OF DESLORATADINE IN pH 5.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
 
Concentration in µgm/ml 
 
Absorbance ( Avg ± SD) 
 
1 
 
2 
 
0.081 ± 0.0021 
 
2 
 
4 
 
0.144 ± 0.0018 
 
3 
 
6 
 
0.233 ± 0.0026 
 
4 
 
8 
 
0.317 ± 0.0016 
 
5 
 
10 
 
0.406 ± 0.0038 
 
6 
 
12 
 
0.482 ± 0.0041 
 
7 
 
14 
 
0.573 ± 0.0054 
 
8 
 
16 
 
0.660 ± 0.0024 
 
9 
 
18 
 
0.741 ± 0.0012 
 
10 
 
20 
 
0.823 ± 0.0047 
                         
R
2
    0.9997 
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TABLE 2: CALIBRATION OF DESLORATADINE IN 0.1N HYDROCHLORIC ACID 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 
 
Concentration in µgm/ml 
 
Absorbance ( Avg ± SD) 
 
1 
 
2 
 
0.060  ± 0.0009 
 
2 
 
4 
 
0.152 ± 0.0008 
 
3 
 
6 
 
0.239 ± 0.0006 
 
4 
 
8 
 
0.323 ± 0.0012 
 
5 
 
10 
 
0.397 ± 0.0012 
 
6 
 
12 
 
0.488 ± 0.0008 
 
7 
 
14 
 
0.562 ± 0.0008 
 
8 
 
16 
 
0.643 ± 0.0012 
 
9 
 
18 
 
0.728 ± 0.0004 
 
10 
 
20 
 
0.798 ± 0.0004 
                         
R
2
    0.9996 
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TABLE NO: 3 DESLORATADINE-INDION 204 DRUG-RESINS COMPLEX 
 
 
 
S.NO 
 
 
DRUG-RESIN RATIO 
 
% OF DRUG BOUND TO RESIN  
 
(Average ± S.D) 
 
 
 
 
1 
 
 
1:1 
 
 
58.93 ± 1.66 
 
 
 
2 
 
 
1:2 
 
 
64.89 ±  1.18 
 
 
 
3 
 
 
1:3 
 
 
61.31 ± 0.32 
 
 
 
4 
 
 
1:4 
 
 
65.53 ± 2.54 
 
 
 
5 
 
 
1:5 
 
 
61.59 ± 3.34 
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TABLE NO; 4 DESLORATADINE-INDION 234 DRUG RESIN COMPLEX 
 
 
 
S.NO 
 
 
DRUG-RESIN RATIO 
 
 
% OF DRUG BOUND TO RESIN  
 
              (Average ± S.D) 
 
 
1 
 
1:1 
 
76.66  ± 0.68 
 
 
2 
 
 
1:2 
 
74.11  ± 0.73 
 
3 
 
1:3 
 
85.25 ± .049 
 
 
4 
 
1:4 
 
85.96 ± 1.17 
 
 
5 
 
1:5 
 
88.19 ± 0.68 
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                                           TABLE NO; 5     FORMULATION OF FAST DISSOLVING TABLET OF DESLORATADINE 
 
Ingredients 
 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
F7 
 
F8 
 
F9 
 
F10 
 
F11 
 
F12 
 
F13 
 
F14 
 
F15 
DRC (Eq.to 5mg of 
desloratadine) (mg) 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
 
34.45 
Sodium 
starchglycolate(mg) 
 
3 
 
6 
 
9 
 
12 
 
15 
  _ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
 
Crospovidone (mg) 
 
_ 
 
 
_ 
 
_ 
 
_ 
 
_ 
 
3 
 
6 
 
9 
 
12 
 
15 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
Croscarmellose 
sodium(mg) 
 _ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
 
 
3 
 
6 
 
9 
 
12 
 
15 
 
Mannitol (mg) 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
55 
 
Microcrystalline 
cellulose(mg) 
 
99.55 
 
96.55 
 
93.55 
 
90.55 
 
87.55 
 
99.55 
 
96.55 
 
93.55 
 
90.55 
 
87.55 
 
99.55 
 
96.55 
 
93.55 
 
90.55 
 
87.55 
Sodium saccharin 
(mg) 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
 
3 
Peppermint flavor 
(mg) 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
Magnesium stearate 
(mg) 
 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
 
2 
Talc (mg) 
 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
 
1 
Total Weight (mg)  
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
 
200 
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TABLE NO; 6    EVALUATION OF MIXED BLEND OF DRC AND EXCIPIENTS 
 
Formulation 
 
Angle of 
repose(˚) 
 
Bulk density 
(g/cm
3
)
 
 
Tapped density 
(g/cm
3
) 
 
Compressibility 
index (%) 
 
Hausner’s ratio 
 
Drug content        
(%) 
F1 31.79 0.50 0.59 15.78 1.1874 97.78 
F2 30.27 0.52 0.59 11.10 1.1249 101.23 
F3 30.80 0.49 0.53 10.54 1.1177 97.78 
F4 29.91 0.47 0.52 9.98 1.1109 100.49 
F5 29.49 0.50 0.56 10.54 1.1178 98.27 
F6 29.74 0.50 0.56 10.53 1.1176 98.52 
F7 29.92 0.50 0.55 10.53 1.1177 97.04 
F8 29.07 0.49 0.55 10.54 1.1178 97.78 
F9 29.51 0.47 0.52 10 1.1111 99.01 
F10 29.55 0.49 0.55 10.52 1.1175 96.79 
F11 29.25 0.50 0.55 10.52 1.1176 99.26 
F12 29.49 0.49 0.56 10.53 1.1176 98.76 
F13 28.35 0.49 0.55 10.48 1.1170 97.04 
F14 28.84 0.49 0.55 10.52 1.1176 98.52 
F15 28.72 0.49 0.56 10.53 1.1176 99.01 
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TABLE NO; 7       EVALUATION OF FAST DISSOLVING TABLETS 
Formulation 
code  
Thicknes
s (mm)  
Diameter 
(mm) 
Hardness
(Kg/cm2) 
Weight 
variation 
range(mg) 
Friability 
(%) 
Water 
absorption 
ratio (%) 
Wetting 
time 
(sec) 
Content 
uniformity (%) 
Disintegration 
time (sec) 
Max % of drug 
release at 10 min     
(Avg ± S.D) 
         F1 3 8 3 202.08-234.84 0.79 55.26 47 97.78 48 95.82 ± 0.67 
F2 3 8 3 200.84-233.4 0.88 59.07 56 101.23 47 95.75 ± 1.095 
F3 3 8 3 191.9-223 0.63 68.60 40 97.78 44 96.42±   0.538 
F4 3 8 3 204.12-237.2 0.69 75.13 35 100.49 30 91.83 ± 0.66 
F5 3 8 3 179.24-208.3 0.36 86.27 27 98.27 20 92.19 ± 0.844 
F6 3 8 3 182.04-211.56 0.67 63.91 26 97.53 23 96.68 ± 0.658 
F7 3 8 3 182.93-212.59 0.38 72.83 14 96.55 16 94.54 ± 0.586 
F8 3 8 3 178.78-207.76 0.47 80.71 8 96.79 10 93.48 ± 0.588 
F9 3 8 3 179.92-209.08 0.71 88.27 8 95.56 8 96.55 ± 0.528 
F10 3 8 3 185.72-215.82 0.58 91.71 5 96.05 6 97.12 ± 0.374 
F11 3 8 3 178.52-207.46 0.57 69.97 17 97.78 15 90.95 ± 0.374 
F12 3 8 3 183.12-212.8 0.87 77.65 16 98.02 13 91.55 ± 0.769 
F13 3 8 3 184.13-213.97 0.9 78.17 17 96.55 14 93.43 ± 0.597 
F14 3 8 3 184.51-214.43 0.83 82.05 14 98.27 11 95.09 ± 0.757 
F15 3 8 3 182.97-212.63 0.72 83.92 11 97.78 10 93.71 ± 0.527 
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FIGURE: 1 
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FIGURE: 2 
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FIG 3 FTIR SPECTRA DRUG 
 
 
 
INDION 234 
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DSC THERMOGRAMS 
 
FIGURE 4 DRUG 
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FIG 5 
COMPARISON OF INVITRO RELEASE PROFILE OF DESLORATADINE CONTAINING DIFFERENT PERCENTAGE 
OF SODIUM STARCH GLYCOLATE 
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FIG 6 
COMPARISON OF INVITRO RELEASE PROFILE OF DESLORATADINE CONTAINING DIFFERENT PERCENTAGE 
OF CROSPOVIDONE 
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FIG 7 
COMPARISON OF INVITRO RELEASE PROFILE OF DESLORATADINE CONTAINING DIFFERENT PERCENTAGE OF 
CROSCARMELLOSE SODIUM 
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 FIG 8 
COMPARISON OF INVITRO RELEASE PROFILE OF DESLORATADINE CONTAINING DIFFERENT SUPER 
DISINTEGRANTS 
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CHAPTER-XI 
SUMMARY AND CONCLUSION 
Desloratadine is a selective, H1 receptor antihistamine drug having bitter in 
taste. It is the major orally active metabolite of loratadine, approved for allergic rhinitis 
and/or chronic idiopathic urticaria. Problems like hand tremors, dysphasia and non-co-
operative patients, the problems of swallowing is a common phenomenon which leads 
to poor patient compliance and ineffective therapy. 
Fast dissolving tablets are gaining prominence as a new drug delivery system, 
which disintegrate or dissolve in the oral cavity within a minute without the need of 
water or chewing. In the present study, an attempt has been made to prepare bitterless 
fast dissolving of desloratadine with good mouth feel so as to prepare a “patient-
friendly dosage form”. 
The drug is dispersed in purified water under stirring at 100rpm in room 
temperature. The ph of the drug dispersion is adjusted to PH 6.5± 0.5 with 2% citric 
acid solution. The resin is then added to the ph adjusted drug dispersion and stirred for 
3 hours. The dispersion is filtered through whatman filter paper NO; 41. 
The DRC is formed with two resins (INDION-204, INDION-234). In each case 
100mg of drug in deionised water is stirred with resin containing various drug-resin 
ratio (1:1, 1:2, 1:3, 1:4, 1;5) by using magnetic stirrer. Then the dispersion is filtered 
through whatman filter paper NO; 41.The amount of drug loaded is determined 
indirectly by estimating the amount remaining to be loaded in solution 
spectrometrically at 242 nm in UV-Spectrophotometer. The resin to which the drug 
bound to maximum percentage is selected for further studies. 
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An accurately weighed quantity of DRC is mixed with different ratio (1.5%, 
3%, 4.5%, 6% and 7.5%) of superdisintegrants (CCS, CP, SSG).The drug resin 
complex along with MCC, Mannitol, Saccharin sodium and Peppermint flavor in 
geometrical dilution. Then Magnesium stearate and Talc were added, mixed and 
compressed into tablets using single punch tablet punching machine. 
Disintegration time is measured in 900ml of artificial Saliva (PH 5.8) at 
37±	0.5℃.The disintegration time of 3 tablets are recorded and the average is reported. 
Dissolution test is determined by USP dissolution testing apparatus type-
2(paddle method). It is performed using 900ml of 0.1N Hydrochloric acid at 37±	0.5℃ 
and 50 rpm. A 5ml sample solution is withdrawn from the dissolution apparatus at 5, 
10, 15, 20, 25 and 30 minutes. The samples are replaced with fresh dissolution medium 
of same quantity. The absorbance of the solution is measured at 242 nm in UV-
Spectrophotometer. 
Indion-234 resin was selected for the preparation of DRC (1:5). The maximum 
drug loading found to be 88.19±0.68%. The disintegration time of the tablets decreased 
with increase in concentration of superdisintegrants. The faster disintegration effect of 
crospovidone tablets may be attributed to its rapid capillary activity and pronounced 
hydrating with little tendency to gel formation. The fast dissolving tablet formulations 
were subjected to precompression and post compression parameter and the results were 
found to be within the acceptable limits. In vitro dissolution studies of the all 
formulation showed more than 90% drug release within 10 minutes. The maximum 
increase in the dissolution rate was observed with 7.5% Crospovidone (F-10) amongst 
all formulation.  97.12±	0.37%	release was occurring within 10 minutes.F-10 was 
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found to be best formulation as this showed less disintegration time and more drug 
release. 
Conclusion: 
     Use of cation exchange resins offers good method for preparing bitterless 
desloratadine formulation using drug-resin complex. Fast dissolving tablets of 
desloratadine can be successfully prepared by direct compression method using 
selected superdisintegrants in order to improve disintegration/dissolution of the drug 
in oral cavity and hence better patient compliance and effective therapy. 
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